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ABSTRACT 
 
LINDSAY FAIRCLOTH RIZZARDI: Epigenetic Factors Are Dynamically 
Regulated Throughout The Cell Cycle And Are Required For Efficient DNA 
Replication 
(Under the direction of Dr. Jeanette Gowen Cook) 
 
 Chromatin consists of DNA wrapped around a core of histone proteins that 
can be modified to elicit distinct cellular responses. All DNA-templated processes 
including DNA replication must function within the context of chromatin. The 
focus of this study is the interaction between the replication machinery and the 
chromatin structure it must traverse to faithfully replicate the genome. Individual 
histone modifications can promote recruitment of replication proteins directly or 
recruit chromatin remodelers that increase the accessibility of the underlying 
DNA. Our studies in budding yeast, Saccharomyces cerevisiae, have identified a 
specific histone modification, H3K4me2, that promotes efficient DNA replication; 
although, the mechanism of this regulation remains unclear. Additionally, we 
found that the enzyme responsible for depositing H3K4me2 is cell cycle 
regulated, being most abundant during G1 when cells prepare the genome for 
DNA replication.  
Another histone modification required during G1 for proper DNA 
replication is H4K20me1. As this modification is not found in budding yeast, our 
studies were undertaken in a mammalian cell culture system. The enzyme 
responsible for this modification had previously been identified as Set8 (a.k.a. 
PR-Set7) and we have begun investigating the regulation of this enzyme 
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throughout the cell cycle and during a cellular stress response. This enzyme is 
degraded both during S phase and after UV-induced DNA damage by the 
CRL4Cdt2 E3 ubiquitin ligase complex. We discovered that this degradation after 
DNA damage is abrogated during mitosis and after osmotic stress. This 
mechanism is conserved for at least one other CRL4Cdt2 substrate, Cdt1, that is 
an essential replication factor. Protection from UV-induced degradation requires 
active Cdk1 during mitosis as inhibition of this kinase leads to degradation of 
both Set8 and Cdt1. We are currently investigating whether this is a direct or 
indirect effect. During osmotic stress in asynchronous cells, the stress MAPKs 
p38 and JNK may play a more important role than Cdk1. It is clear that the 
histone modifications and the enzymes responsible for their deposition are critical 
components ensuring proper DNA replication and as such are tightly regulated. 
Future work will elucidate the exact mechanisms by which these chromatin 
factors influence DNA replication. 
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CHAPTER 1 
 
Introduction 
The cell cycle is a tightly regulated process that directs cell growth, 
ensures accurate duplication of the genome, and produces two identical 
daughter cells. Maintaining genome integrity is a top priority throughout this 
process. To accomplish this feat, every facet of DNA replication is under multiple 
layers of regulatory surveillance ensuring that the genome is prepared for 
replication in G1, that replication is completed error-free during S phase, and that 
the chromosomes segregate properly during mitosis. When any aspect of this 
process goes awry, DNA can become damaged resulting in gene mutation, 
chromosome rearrangements, and aneuploidy, all of which are hallmarks of 
cancer (1). Replicating the genome, like all DNA-templated processes, involves 
navigating the three-dimensional nuclear space to gain access to the DNA; this 
access is often restricted by the compaction of DNA into chromatin. 
Chromatin consists of 147 bp of DNA wrapped around an octamer of 
histone proteins (2 each of histones H2A, H2B, H3, and H4) that form 
nucleosomes. Histone proteins possess unstructured N-terminal tail regions that 
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can be post-translationally modified by phosphorylation, acetylation, methylation, 
ubiquitination, etc. (2). In the case of methylation, up to three methyl groups can 
be added to a single lysine residue, and there is evidence that these methylation 
states are functionally distinct (3). These post-translational modifications (PTMs) 
can alter DNA accessibility, serve as recognition sites for other proteins, and 
stabilize protein complexes (reviewed in reference 4). High levels of histone 
acetylation exist in easily accessible, highly transcribed euchromatin, while the 
much more compact heterochromatin tends to be hypoacetylated. It has been 
proposed that various combinations of histone modifications act as a “histone 
code” that provides epigenetic information to regulate DNA processes (5). It is 
likely that some aspect of this histone code is involved in the regulation of DNA 
replication. 
Origins of replication 
  
Sequence determinants 
 
DNA replication is initiated at sites in the genome known as origins of 
replication. These sites were first identified in budding yeast, Saccharomyces 
cerevisiae, by isolating DNA sequences that were capable of directing plasmid 
replication. This work led to the identification of a conserved sequence element 
termed the autonomously replicating sequence (ARS). The ARS contains a 
highly conserved but degenerate 11-bp ARS consensus sequence [ACS; 
(T/A)TTTAT(A/G)TTT(T/A)] along with three poorly defined B elements (B1, B2, 
and B3) that are nonetheless important for origin function (reviewed in reference 
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6). These B elements, while not conserved, can serve as binding sites for 
transcription factors or DNA unwinding elements (DUE) (7). 
Identifying replication origins in eukaryotic systems other than yeast has 
been much more difficult for two main reasons. The first is that there is no 
conserved sequence element common to replication origins in other eukaryotes. 
While these regions tend to be AT-rich there is no defined sequence that confers 
origin activity (8). The second is the lack of sensitive and stringent methods for 
isolating mammalian origins on a genome-wide scale. Origin identification can 
become complicated by the fact that origins are not uniformly active or efficient 
making it difficult to confidently confirm any but the most robust origins. Until 
recently, S. cerevisiae was the only organism in which all of the origins had been 
functionally identified. There have since been many technological advances that 
have successfully identified origins in more complex eukaryotes; however, these 
data sets often show very little overlap (<40%) (reviewed in reference 9). The 
techniques utilized include short nascent strand sequencing, ChIP-seq, Repli-
Seq, or combinations of these, and have allowed identification of origins even in 
human cells (10-12). Massive deep sequencing of short nascent strands from 
four different human cells lines has recently yielded what is now regarded as a 
complete map of replication origins in human cells. Approximately 250,000 
origins of replication were mapped nearly ten times the number of origins that 
had previously been predicted to exist (13). Despite this new information, the 
underlying factors regulating origin position in the genome are still unclear. Even 
in S. cerevisiae the ACS element is not the sole determinant of origin activity 
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because this sequence occurs in excess of 12,000 times throughout the genome 
and only ~ 400 functional origins exist (14). In addition, the aptly named origin 
recognition complex (ORC) binds specifically to the ACS, but is still unable to 
define active origins as it binds to more than 400 loci (15). In metazoans where 
no sequence element has been identified, ORC prefers to bind AT-rich 
sequences and metazoan origins tend to be 70-80% AT-rich (8). It is clear that 
neither DNA sequence nor ORC binding are sufficient to define origins of 
replication. This fact has lead researchers to investigate epigenetic determinants 
of origin identity, specifically the role of chromatin in origin determination. Recent 
studies have shown the importance of the chromatin environment in regulating 
many cellular processes including DNA replication (16-18).  
Chromatin structure 
 
Genome-wide analysis of nucleosome positioning in yeast and 
mammalian cells have shown that early replicating origins exist in nucleosome-
free regions (NFRs) that are easily accessed by the replication machinery (19-
21). Origins in all organisms tend to be AT-rich and these poly-A stretches resist 
bending, thus excluding nucleosomes (8,22). Interestingly, ORC helps to 
maintain NFRs and promotes the proper phasing of nearby nucleosomes that is 
needed for efficient DNA replication (23). Proper nucleosome phasing and 
nucleosome position relative to the origin of replication is important for optimal 
origin function. Shifting nucleosomes either towards or away from the origin NFR 
negatively impacts origin activity. Origins are frequently found near transcription 
start sites (TSS) that are also nucleosome free and are flanked by nucleosomes 
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rich in “activating” histone modifications (such as H3K4me2, 3 and H3 and H4 
acetylation). Additionally, origin firing time is correlated with transcription (24-26). 
In transcriptionally inactive regions, histone-modifying enzymes are recruited to 
origins to facilitate binding of the replication machinery. In Drosophila S2 cells for 
example, the histone acetyltransferase complex SAGA (Spt-Ada-Gcn5 
acetyltranferase) and the chromatin remodeler Brahma were found to promote 
ORC recruitment to these heterochromatic regions (27). 
When our work began, little was known about how the chromatin 
environment influenced origin activity or position in the genome. However, it was 
demonstrated by many groups (predominately in yeast and Drosophila 
melanogaster) that manipulating histone acetylation could alter the timing of 
replication initiation from origins, or origin “firing”, in S phase. Origins located in 
compact, hypoacetylated heterochromatin tended to fire late in S phase, but 
moving these origins to more “open”, euchromatic regions allowed them to fire 
early in S phase (28). Similarly, increasing global histone acetylation by deleting 
a histone deacetylase (Rpd3) resulted in a shorter S phase due to earlier origin 
firing genome-wide (29). Conversely, tethering a histone acetyltransferase 
(Gcn5) to a normally late-firing origin caused it to fire much earlier in S phase. In 
budding yeast, examination of the dynamics of histone acetylation at an 
individual origin of replication (ARS1) revealed that H3 and H4 tail acetylation 
was lowest during G1 and increased dramatically during S phase, consistent with 
a role for histone acetylation in origin firing (30). However, this could be a 
consequence of histone turnover as newly synthesized histones in all eukaryotic 
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cells are acetylated at H4K5 and K12; although, why these acetyl marks are 
important for new histone incorporation is unclear since unmodified H3-H4 
dimers are readily incorporated into new nucleosomes in vitro (31-33). Work from 
many groups has extended these findings and revealed that high levels of 
histone acetylation are correlated with origin activity even in human cells 
(25,30,34-36).  
Histone PTMs 
 
Researchers have struggled to identify a distinct set of histone 
modifications (or a chromatin signature) that determines the location of 
replication origins in the genome. While this identification has proven to be quite 
difficult, histone modifications that are enriched at origins have been identified, 
and functional studies have shown that individual histone modifications can 
regulate origin activity (Table 1.1). Through these efforts, a picture is emerging of 
the chromatin structure surrounding origins. Mass spectrometry analysis of an 
isolated yeast origin identified several previously unknown histone modifications 
that were specific to origins: H4K79ac, H3K23ac, H3K37me1, and H2AS15 
phosphorylation (30). This study also identified a novel histone modification that 
was specifically absent from origins, H2BK111me. Interestingly, H3K37me1 was 
entirely absent during S phase and was always found in conjunction with 
H3K36me1 on the same histone tail. However, another modification enriched at 
origins, H3K27ac, was never found on the same tail as H3K36me1, or me2. 
H3K36me1 was previously shown to promote association of the replication 
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initiation factor Cdc45 with origins (37). Work to define the role of H3K37me1 in 
replication is currently underway in the Kouzarides lab.  
Many other histone modifications are also enriched at origins and 
influence DNA replication. In S.cerevisiae, H3T45 is phosphorylated by the Cdc7-
Dbf4-dependent kinase (DDK) during S phase, and mutation of T45 to alanine 
results in reduced H3K36me3 levels and sensitivity to replication stress caused 
by hydroxyurea (HU) and camptothecin (CPT) (38,39). In human cells 
proliferating cell nuclear antigen (PCNA) specifically recognizes and binds to 
monomethylated H3K56 (methylated by G9a) during G1 (40). In Tetrahymena, 
H3K27me1, but not di- or tri-methylated H3K27, was found to play an important 
role in replication fork progression, and the methyltransferase responsible, TRX1, 
was also shown to interact with PCNA (41). Another histone modification, 
H3K79me2 is highly enriched at origins in human cells and spreads during S 
phase, possibly acting as a marker of replicated regions (42-45). Interestingly, 
depletion of the H3K79 methyltransferase DOT1L leads to low levels of 
rereplication suggesting that H3K79me2 could play a role in preventing aberrant 
replication. A new computational analysis of histone modifications in S. 
cerevisiae has synthesized an “alphabet” of nucleosome characteristics 
associated with different functional elements (46). Origins of replication were 
characterized by low nucleosome occupancy with minimal histone modifications 
(low levels of asymmetric H3R2me2), near non-expressed or lowly expressed 
genes, as had been noted by previous researchers. It is important to note that 
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this work was done on data collected from asynchronous cell populations and 
that many histone modifications at origins are dynamic and cell cycle regulated. 
Many replication proteins influence, and are influenced by, chromatin 
modifying enzymes that are active at origins of replication. These interactions 
can serve to regulate origin activity during all stages of the cell cycle. As 
described in detail below, origins become licensed in G1 phase, fire in S phase 
while origin licensing is inhibited, and are “reset” as cells exit mitosis into the 
subsequent G1 phase. The chromatin structure influences each aspect of this 
process and will be discussed further in the following sections.  
Origin licensing and firing 
 
For DNA replication to successfully duplicate the entire genome, a 
sufficient number of replication origins must initiate replication in S phase. If too 
few origins fire, individual replication forks must travel longer distances making 
them susceptible to fork collapse and subsequent DNA damage. Conversely, if 
origins fire more than once during the cell cycle (a process termed rereplication) 
then replication forks can collide leading to DNA damage (Figure 1.1A). To 
prevent these destructive events, origins of replication are tightly regulated.  
During G1, origins are prepared, or “licensed”, for DNA replication by the 
assembly of pre-replication complexes (preRCs). Origin licensing is complete 
once the replicative helicase of mini-chromosome maintenance (MCM) 
complexes has been loaded onto chromatin at origins through the activity of the 
canonical preRC components (Figure 1.1B). Replication origins are recognized 
and bound by ORC (the first preRC component recruited) that remains 
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associated with origins throughout the cell cycle. The next component, cell 
division cycle 6 (Cdc6), is recruited to origins through direct interaction with ORC. 
In the cytoplasm, Cdc10 protein-dependent transcript 1 (Cdt1) interacts with 
MCM complexes by binding to the Mcm2 and Mcm6 subunits to facilitate their 
import into the nucleus (47-50) At least two Cdt1-MCM complexes are then 
recruited to origins in a step-wise manner through Cdt1 interaction with both 
Cdc6 (49) and Orc6 (51-53). In contrast to ORC and Cdc6, Cdt1 lacks any 
enzymatic activity but is absolutely required for MCM recruitment to origins. It is 
through the ATPase activity of ORC and Cdc6 that the MCM helicase ring is 
opened and loaded onto chromatin while also promoting release of Cdt1 (54). 
While ATP hydrolysis occurs rapidly upon association of the Cdt1-MCM complex, 
actual loading of the MCM double-hexamer onto the DNA occurs some time later 
(55). In human cells, an origin licensing checkpoint exists so that cells will not 
enter S phase or initiate replication unless a sufficient number of origins have 
been licensed in G1 (56,57). While this checkpoint relies on p53 activity and 
hyperphosphorylation of Rb, the exact mechanism by which cells sense how 
many origins have been licensed is still undefined. 
Once MCM complexes have been loaded, the origins are licensed for 
replication and ORC, Cdc6, and Cdt1 are no longer required in order for 
replication to commence in S phase (58,59) However, the loaded MCM 
complexes are not yet active as DNA helicases. As cells reach the G1/S 
transition, a host of replication initiation factors are recruited and form the pre-
initiation complex (PIC) (Figure 1.1C) (60,61). Prior to S-phase cyclin-dependent 
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Figure 1.1 DNA replication is initiated at origins of replication and is tightly 
regulated to prevent spurious replication initiation. A) Normal replication 
requires a sufficient number of origins to fire in S phase. If too few origins fire, the 
DNA may not be fully replicated leading to increased DNA damage and genome 
instability. DNA damage can also occur if replication origins fire multiple times 
during a single cell cycle (rereplication). B) PreRC assembly is restricted to the 
G1 phase of the cell cycle. ORC is the first complex member recruited to origins 
and directly interacts with Cdc6 and Cdt1. Cdt1 recruits the MCM DNA helicases 
and through the ATPase activity of ORC and Cdc6 the MCM complexes are 
loaded onto the DNA. After MCM loading origins are considered to be licensed 
for replication and the other preRC components are not required for subsequent 
DNA replication in S phase. C) As cells transition from G1 to S phase, replication 
initiation factors are recruited and form the PIC. This complex functions to 
activate the MCM DNA helicase and commence replication. During late G1, the 
Dbf4-dependent kinase (DDK) phosphorylates Mcm4 and Mcm6 to promote 
recruitment of Cdc45 and Sld3. As cells enter S phase, CDK activity increases 
and promotes the recruitment of GINS that stabilizes the Cdc45-MCM complex 
(often referred to as the CMG complex). This complex in addition to CDK 
phosphorylation of Sld2 and Sld3 helps to stably recruit Mcm10, Sld2, and Dpb11 
to form the complete PIC. 
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kinase (CDK) activation, DDK phosphorylates Mcm4 and Mcm6 to promote the 
recruitment of Cdc45 and Sld3 during G1 (62). As CDK activity increases at the 
G1/S transition, the Go-Ichi-Ni-San (GINS) complex is recruited and stabilizes 
the Cdc45-MCM interaction. In S. cerevisiae this complex forms the basis for 
recruiting Sld2, Dpb11, and Mcm10 that are then able to activate the MCM 
helicase. In metazoans, TopBP1 and RecQ4 are the homologs of Dpb11 and 
Sld2, respectively. Once the MCM helicase becomes active, the replicative DNA 
polymerases and other DNA processing factors are recruited resulting in 
formation of the complete replisome and commencement of DNA replication in S 
phase (62). 
Origin licensing is tightly regulated to restrict DNA replication to once and 
only once per cell cycle. MCM loading outside of G1 phase must be inhibited 
because new licensing during S and G2 phases can lead to rereplication. The 
consequences of rereplication include gene amplification, chromosomal 
translocation, and aneuploidy that are drivers of oncogenesis (1). Origin licensing 
is restricted to G1 through many non-redundant mechanisms including 
transcriptional regulation, protein re-localization, expression of protein inhibitors, 
and ubiquitin-mediated proteolysis of both licensing components and cell cycle 
regulators. These mechanisms are discussed in detail as they pertain to each 
replication factor in the following sections. 
ORC and ORCA 
 
ORC is currently recognized as the first critical determinant of origin 
identity and is recruited to origins during late M phase. ORC consists of the core 
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complex of Orc2-5 with Orc1 and Orc6 more weakly associated. Orc1 is the 
largest ORC subunit and is essential for preRC formation while Orc6 is 
dispensable for preRC formation in vitro (63,64). ATP hydrolysis by Orc1 
releases the MCM complex from ORC to complete MCM loading onto chromatin 
(54,65). While in yeast all ORC subunits are stably bound throughout the cell 
cycle, in metazoans Orc1 is cell cycle regulated. Orc1 is bound to origins during 
G1, but is largely degraded by the SCFSkp2 ubiquitin ligase complex during S 
phase and reaccumulates as cells transition from mitosis to G1 (66). Studies in 
multiple organisms revealed that ORC is regulated through phosphorylation by 
CDKs (reviewed in reference 8). In budding yeast, Cyclin B-CDK binds to the 
RXL motif of Orc6 and phosphorylates both Orc6 and Orc2 at the G1/S transition 
preventing association of other preRC components (67,68). In mammalian 
systems, Orc1 is phosphorylated by mitotic cyclin-CDKs also resulting in 
inactivation of the complex to prevent rereplication. 
ORC recruitment is relatively straightforward in S. cerevisiae, as it is the 
only organism in which ORC recognizes and binds a conserved sequence 
element, the ACS. However, as previously mentioned, ORC binding sites and 
ACS elements are much more abundant than origins suggesting that other 
factors must be involved in defining origins. Several histone modifications 
influence the recruitment of ORC. The Orc1 subunit contains a conserved bromo-
adjacent homology (BAH) domain that has been shown to promote nucleosome 
binding in eukaryotic cells (23). In metazoans, this domain is able to recognize 
both mono- and di-methylated H4K20 (69). H4K20 is first mono-methylated by 
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Set8 then subsequently di- and tri-methylated by Suv4-20h1 or Suv4-20h2 (70). 
If recognition of H4K20me2 by Orc1 is required for ORC recruitment, then mono-
methylation of H4K20 by Set8 is an essential first step in determining origin 
identity (discussed further below). ORC can also influence deposition of histone 
modifications. In Drosophila, H4K12 and H3K56 acetylation are dependent on 
ORC binding at origins (34,71). Consistent with this fact, Orc1 (as well as Mcm2, 
Cdt1, and geminin) physically interacts with the HAT responsible for H4K12 (and 
H4K5) acetylation in human cells, HBO1 (discussed further below) (35,72-74).  
Another factor involved in origin licensing is the WD40 repeat domain-
containing protein ORC-associated (ORCA; also known as LRWD1) (75). ORCA 
is required at many origins to stabilize the chromatin association of ORC. ORCA 
binds to Orc1 and Cdt1 during G1 phase and Orc2 throughout the cell cycle 
(75,76). Similar to Orc1, ORCA recognizes and binds methylated H4K20, 
specifically H4K20me3 (77). ORCA is most abundant during G1 and levels 
decrease as cells transition into S phase helping to prevent origin licensing 
outside of G1 (76). While ORCA interacts with the ubiquitin ligase CRL4DDB1, 
recent studies suggest that multiple ubiquitin ligases likely target ORCA for 
degradation in S phase (78). Polyubiquitinated ORCA was detected at the G1/S 
transition, and only non-ubiquitinated ORCA associates specifically with Orc2 
suggesting that this interaction may protect ORCA from ubiquitination (75). 
Cdc6 
 
Cdc6 is another preRC component recruited to origins and is a member of 
the AAA+ ATPase family. Cdc6 is dependent on ORC for its chromatin 
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association. Recent structural data on the S. cerevisiae proteins suggests that 
Cdc6 binding actually alters the structure of ORC such that the BAH domain of 
Orc1 is properly positioned (79). The ATPase activity of both ORC and Cdc6 
likely cause destabilization of the MCM ring to allow its loading onto the DNA 
(80,81). During early G1, Cdc6 is targeted for degradation by APCCdh1 (82). 
APCCdh1 prevents Cdc6 accumulation until late in G1 when Cdc6 is 
phosphorylated at serine 54 by Cyclin E-Cdk2 disrupting the interaction between 
Cdc6 and Cdh1 (83). During S phase APCCdh1 is inactivated and Cdc6 is 
exported from the nucleus through a two-step mechanism. First, Gcn5 acetylates 
Cdc6 at three lysine residues (lysines 92, 105, and 109) (84). Cdc6 acetylation is 
required for subsequent phosphorylation at serine 106 by Cyclin A-Cdk2 that 
promotes the nuclear export of Cdc6, preventing its participation in origin 
licensing (85,86). Cdc6 persists in the cytoplasm and is degraded by APCCdh1 in 
the next G1 phase. A recent report suggests that in cycling cells Cdc6 is present 
in late mitosis after anaphase and the bulk of origin licensing occurs during this 
window; in contrast, cells coming out of quiescence must wait until Cdc6 
accumulates during G1 before licensing can occur (87). This tight regulation of 
Cdc6 ensures that preRC formation is restricted to the very narrow windows in 
late mitosis and G1 when Cdc6 is present in the nucleus. 
Cdt1 
 
Cdt1 is the only preRC component that lacks enzymatic activity, but it is 
critical for origin licensing, as it is responsible for the recruitment of the MCM 
helicase at origins of replication. An auto-inhibitory domain in Mcm6 prevents 
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recruitment of the MCM complex to ORC-Cdc6, but through interaction with Cdt1, 
this inhibition is relieved. Deleting this auto-inhibitory region allows Cdt1-
independent MCM recruitment to ORC-Cdc6 in vitro, but not helicase loading 
(55,88). Cdt1 has also been suggested to facilitate origin licensing by enhancing 
chromatin accessibility (72). Cdt1 directly interacts with HBO1 (89) and histone 
acetylation by HBO1 is critical for origin licensing (35,73). During G1, histone H4 
acetylation by HBO1 positively influences origin licensing by promoting large-
scale chromatin decompaction as evidenced by an elegant immunofluorescence 
assay (72). During S phase this process is reversed through binding of HDAC11 
to Cdt1-geminin complexes resulting in decreased histone acetylation. This 
“chromatin reset” provides an additional mechanism to restrict origin licensing to 
the G1 phase of the cell cycle. Clearly, Cdt1 is at the center of many regulatory 
mechanisms that ensure DNA replication takes place once and only once during 
the cell cycle. 
Degradation of Cdt1 can be prevented by acetylation at lysines 24 and 29 
by p300 and PCAF in asynchronously dividing 293T cells (90). These acetylated 
lysines were detected during early G1. During S phase however, HDAC11 
associated with and deacetylated Cdt1 promoting Cdt1 degradation (90). It is 
unclear which E3 ubiquitin ligase Cdt1 is protected from by acetylation, but the 
proximity of K24 to T29 suggests that it could interfere with Skp2 binding, 
although this has not yet been tested. Further work is needed to fully understand 
the importance of Cdt1 acetylation/deacetylation during G1 and S phases.  
MCM DNA helicase 
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The MCM complex is a heterohexamer that functions as the replicative 
helicase. Recent data has demonstrated that two MCM complexes are loaded at 
origins in a head-to-head conformation (51). While these two are sufficient to 
commence replication, it has been shown that between 10-20 MCM complexes 
can be loaded at origins in vertebrates (91). Mcm3 stimulates the ATPase activity 
of ORC and Cdc6 to promote multiple rounds of ATP hydrolysis allowing the 
sequential loading of multiple MCM complexes onto origin DNA (88). The 
chromatin decompaction that occurs during preRC formation could “make room” 
for loading additional MCM complexes (72). These extra MCM complexes can 
initiate replication from dormant origins when cells experience replication stress, 
thus protecting the DNA from becoming damaged (92,93). On its own, the MCM 
complex is a poor helicase but as cells transition from G1 to S phase, replication 
initiation factors (Cdc45 and GINS) are recruited and, after phosphorylation by 
Cyclin B-CDKs and DDK, activate the MCM helicase (60).  
Localization of MCM complexes is tightly regulated in S. cerevisiae, but 
not in other eukaryotes, such that they are only present in the nucleus during G1 
and S phase (reviewed in reference 6). After translation in the cytoplasm, only 
intact MCM heterohexamers can enter the nucleus due to the nuclear localization 
sequences (NLS) being present only in Mcm2 and Mcm3. During S phase as 
MCMs are displaced from the DNA, Cyclin B-CDK activity promotes nuclear 
export of Mcm4 (94). Levels of MCMs in the nucleus of other eukaryotes remains 
unchanged throughout the cell cycle (reviewed in reference 95).  
The preRC components discussed above represent the well-established 
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complex that is sufficient for in vitro origin licensing. However, two other factors 
were recently found to be both necessary for origin licensing and sufficient to 
promote recruitment of the canonical preRC components. These two factors are 
both involved in the post-translational modification of histone proteins. They are 
histone acetyltransferase binding to ORC (HBO1) and the histone 
methyltransferase Set8 (a.k.a. PR-Set7). 
HBO1 
HBO1 is a member of the MYST domain family of histone 
acetyltransferases (HATs) that acetylates histone H4 primarily at K5 and K12. It 
is the catalytic subunit of a HAT complex consisting of JADE1 (scaffold protein), 
hEaf6, and ING4 or ING5 (96-98). The two plant homeo domain (PHD) fingers of 
JADE1 are required for chromatin binding while the PHD finger of ING5 can 
direct binding specifically to regions with H3K4me2, 3 (96,97). A recent study of 
the lamin B2 origin in human cells revealed that H3K4me3 peaks during mid-G1 
at this origin and is required for HBO1 recruitment and subsequent tetra-
acetylation of H4 (at K5, 8, 12, and 16) (99). 
HBO1 interacts with Orc1, Mcm2, and Cdt1 (73,74,89). When HBO1 was 
depleted in human cells, MCMs failed to load even though the chromatin 
association of ORC, Cdc6, and Cdt1 was unaffected (89,100). Histone H4 
acetylation by HBO1 is not required for ORC binding but is critical for MCM 
loading (35). While HBO1 is not present in S. cerevisiae, a related MYST domain 
family member, Sas2, has been shown to genetically interact with ORC 
suggesting that the HAT-ORC interaction is conserved (101). The interaction of 
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HBO1 with Cdt1 seems to stimulate Cdt1-dependent rereplication suggesting it 
functions as a coactivator of Cdt1 (89). HBO1 interacts with Cdt1 during G1, but 
in S phase two mechanisms counteract HBO1 activity. First, HDAC11 associates 
with Cdt1 resulting in deacetylation of H4, which prevents re-loading of MCMs 
(72). Second, HBO1 HAT activity is inhibited when Cdt1 is bound by its inhibitor 
geminin. Geminin actually strengthens the interaction of HDAC11 with Cdt1 
(35,72).  
During mitosis HBO1 is bound and phosphorylated at serine 57 by Polo-
like kinase 1 (Plk1). This phosphorylation seems to be required for its role in 
promoting MCM loading in G1 such that when this site is mutated cells arrest in 
G1 and fail to load MCMs (102). In fact, tethering the Drosophila HBO1 homolog, 
Chameau, to an artificial origin resulted in increased origin activity (36). 
Additionally, tethering HBO1 to an inactivated c-myc origin in human cells was 
sufficient to activate the origin, as was tethering of Cdt1, Orc2, or E2F1 (103). 
During cellular stress, the interaction between HBO1 and Cdt1 seems to be 
disrupted due to Jun N-terminal kinase (JNK)-dependent phosphorylation 
(discussed in Chapter 3) (104). HBO1 is clearly an important chromatin modifier 
that regulates origin function and whose recruitment to origins could be attributed 
to interactions with both preRC components and methylated H3K4.  
Set8 
 
Set8 (a.k.a. PR-Set7) is the sole methyltransferase responsible for the 
monomethylation of histone H4 at lysine 20 (H4K20me1) and has emerged as a 
critical player in origin licensing (105-107). This protein is highly conserved in 
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eukaryotes, but is not found in S. cerevisiae. Interestingly, in 
Schizosaccharomyces pombe the Set8 homolog, Set9, is responsible for the 
deposition of all three H4K20 methyl states. Set8 methylation of H4K20 is 
impaired when H4K16 is acetylated (108-110). This obstruction is overcome 
through the association of the HDAC SirT2 with Set8. SirT2 not only deacetylates 
H4K16 to allow H4K20 methylation by Set8, but it also deacetylates Set8 at 
lysine 90 resulting in the spread of H4K20me1 (110). The HAT responsible for 
Set8 K90 acetylation has not yet been identified.  
Set8 plays a critical role in origin licensing and its regulation is as 
important as that of Cdt1 for preventing licensing outside of G1 phase. 
H4K20me1 is enriched at origins of replication in Drosophila (111). Knockdown of 
Set8 in human cells results in decreased chromatin association of ORC, Cdc6, 
and MCM complexes (112). Conversely, tethering human Set8 to a non-origin 
genomic locus is sufficient to promote the chromatin-association of ORC and 
MCM complexes (112). A recent mass spectrometry study identified Orc3 as a 
potential interacting partner of Set8 (113). In addition, loss of SetD8 in mice 
results in embryonic lethality and indicates the essential requirement for Set8 
during development (112). The role of H4K20me1 in DNA replication is likely 
exerted through effector proteins that specifically bind this modification. One such 
protein is L3MBTL1, a human homolog of the Drosophila polycomb tumor 
suppressor that may facilitate replication protein recruitment to chromatin through 
its interaction with components of the replication machinery (Cdc45, PCNA, and 
MCM) (114,115). Alternatively, H4K20me1 could promote origin licensing in G1 
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by serving as the template for di- and tri-methylation by both Suv4-20h1 and 
Suv4-20h2 methyltransferases at origins of replication (70,116,117). The BAH 
domain of Orc1 was recently shown to bind H4K20me2 while the preRC-
associated protein, ORCA, specifically binds to H4K20me3 (76,77). The 
decrease in H4K20me1 during S phase could thus be due in part to the transition 
to these higher methylation states, although these marks have not yet been 
specifically examined at replication origins genome-wide. Loss of both Suv4-
20h1 and Suv4-20h2 causes defects in S phase entry, but the effects are less 
severe than loss of Set8 suggesting additional roles for Set8 (and H4K20me1) in 
the G1/S transition (106,117).  
As with many origin licensing factors, Set8 abundance is regulated both 
transcriptionally and post-translationally. SETD8 gene expression fluctuates 
throughout the cell cycle, peaking in mitosis while Set8 protein levels drop during 
S phase even when SETD8 is expressed from a constitutive promoter (118,119).  
Recently, the 3’UTR of Set8 was identified as a target of microRNA-7 in breast 
cancer cells (120). Ubiquitin-mediated proteolysis by SCFSkp2, CRL4Cdt2 and 
APCCdh1 is largely responsible for regulating Set8 protein abundance (109). Both 
SCFSkp2 and CRL4Cdt2 target Set8 for degradation during S phase (118,121). 
Aberrant Set8 accumulation during this cell cycle phase results in rereplication 
that is dependent on the catalytic activity of Set8 (112,122). The ability of a 
stabilized Set8 to induce rereplication further highlights its role in promoting origin 
licensing and the importance of its proper regulation. As cells enter mitosis, Set8 
is phosphorylated at serine 29 by Cyclin B-Cdk1 preventing ubiquitination of Set8 
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by APCCdh1. During early anaphase however, Set8 is dephosphorylated by the 
Cdc14 phosphatases resulting in APCCdh1-mediated proteolysis and reduced 
protein levels during early G1 (123). As a result, Set8 and H4K20me1 levels 
peak in G2/M, are dramatically reduced during mid to late G1, and remain low 
during S phase.  
The absence of the Set8 methyltransferase can only result in 
corresponding changes in histone methylation if histone H4K20me1 is 
simultaneously converted either to unmethylated H4K20 by a demethylase 
(PHF8) or to H4K20me2, 3. PHF8 plays an important role in the G1/S transition 
by demethylating H4K20me1 at promoters of E2F-dependent genes during G1 
(124). PHF8 is recruited to these sites through the interaction of its PHD domain 
with H3K4me2 and me3. Just as PHF8 is recruited to promoters through 
interaction with H3K4me2, 3, it could also be targeted to origins of replication by 
the same mechanism since H3K4me2 and me3 are also present at those loci 
(25).  
An alternative mechanism for Set8’s role in DNA replication could be the 
methylation of an as yet unidentified non-histone protein required for progression 
from G1 to S phase. Currently the only non-histone substrates of Set8 that have 
been identified are p53 and Numb (125,126). These three proteins form a 
complex and when p53 and Numb are methylated, target gene expression is 
reduced and Numb dissociates from p53 resulting in increased p53 degradation 
(125,126). However, it is unlikely that p53/Numb methylation is responsible for 
the replication defects caused by Set8 depletion because the replication 
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phenotypes upon depletion of Set8 are not entirely p53 dependent, and p53 null 
cells are viable (111,127,128). The precise mechanism by which Set8 promotes 
cell cycle progression is therefore still unclear.  
Preventing rereplication 
 
 In summary, origin licensing is a highly orchestrated event and there are 
many mechanisms in place to prevent spurious origin activation and subsequent 
rereplication that ultimately results in genome instability. PreRC formation is 
restricted to the G1 phase of the cell cycle by many non-redundant mechanisms. 
The first is inactivation of the ORC complex by S-phase CDK phosphorylation of 
Orc2 and Orc6. The second involves regulation of Cdc6 levels. In S. cerevisiae, 
Cdc6 is degraded by the SCF Ccd4 E3 ubiquitin ligase complex when it becomes 
active during S phase. However, in metazoans a fraction of Cdc6 is exported to 
the cytoplasm after phosphorylation by Cyclin A-Cdk2. The third mechanism 
involves inhibition of Cdt1 by geminin and Cdt1 degradation by SCFSkp2 and 
CRL4Cdt2. In S. cerevisiae, both Cdt1 and the MCM complex are exported from 
the nucleus in response to CDK-dependent phosphorylation (68,94,129). A fourth 
mechanism is degradation of Set8 by CRL4Cdt2. Fifth, HBO1 acetylation of H4 at 
origins is prevented outside of G1 through disruption of the HBO1-Cdt1 
interaction upon geminin binding, and the association of HDAC11 which 
deacetylates H4 preventing MCM loading. 
Unanswered questions 
  
 At the time this study was undertaken, many of the histone modifications 
discussed above were not known to be involved in DNA replication. Our goal was 
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to identify individual histone modifications that promote or hinder origin licensing 
to determine a chromatin signature denoting origin locations in the genome. 
What has become apparent throughout this work is that origins are not all 
regulated in the same way. Some S. cerevisiae origins are highly dependent on 
the BAH domain of Orc1 interacting with a nearby nucleosome while others 
function normally when this domain is deleted (23). There is also a small subset 
of origins that are negatively regulated by the HDAC Sir2 and have a stably 
positioned nucleosome near or overlapping the B2 element (130-132). A recent 
study in a near-normal EBV-transformed lymphoblastoid cell line found that early 
and late firing origins are regulated by very different mechanisms driven primarily 
by epigenetic factors and influenced only slightly by DNA sequence or 
transcriptional activity (133). While these findings were not unexpected, they do 
reveal the importance of chromatin in origin regulation. Further, this high level of 
complexity and the dynamic nature of these modifications create difficulty in 
pinpointing the factors that confer origin identity.  
The discovery in mammalian cells that H4K20 mono-methylation by Set8 
is a likely first step in origin licensing has led us, and others, to ask how this 
enzyme is recruited to origins. Is it really the first factor recruited to origins, or 
does it interact with other preRC components (e.g. ORC) such that they are 
recruited together? Current work in our lab is attempting to answer this question. 
Additionally, we are interested in how Set8 is regulated during the cell cycle and 
in response to various cellular insults to maintain genome integrity. 
 
  
 
 
 
 
CHAPTER 2 
 
H3K4 di-methylation promotes DNA replication origin function 
in Saccharomyces cerevisiae1 
INTRODUCTION 
DNA replication initiates at discrete genomic loci termed origins of 
replication.  Each eukaryotic chromosome is replicated from many individual 
origins to ensure complete and precise genome duplication during each cell 
division cycle. Individual origins vary both in the likelihood that they will initiate 
replication, or “fire”, in any given S phase and in the firing time within S phase 
(16,134). Highly efficient origins fire in most cell cycles, whereas inefficient 
origins fire in only some cycles and are usually passively replicated by forks 
emanating from neighboring efficient origins. Though highly efficient origins that 
support initiation in most cell cycles have been identified in many genomes, the 
chromosomal determinants of origin location and function are still incompletely 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1Modified from Rizzardi LF, Dorn ES, Strahl BD, and Cook JG. Genetics. October 
2012, Volume 192, pages 371-384. 	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understood. Strikingly, while DNA sequence elements can be necessary, it is 
clear that sequence alone is insufficient to fully specify eukaryotic origin location 
and activity (135,136).  
Like all DNA-templated processes, replication occurs on chromatin. 
Recent progress in the field has demonstrated that the chromatin structure 
surrounding origins plays an essential role in controlling origin activity. For 
instance, the positioning of nucleosomes near origins can either stimulate or 
inhibit origin function (6,19,20,131,137,138). The major protein components of 
chromatin, the histone proteins, can also be post-translationally modified by 
acetylation, methylation, phosphorylation, ubiquitination, and sumoylation (2,139). 
These modifications can alter DNA accessibility and serve as recognition sites for 
other proteins. Importantly, several individual histone modifications affect aspects 
of origin function. For example, acetylation of histones H3 and H4 accelerate the 
timing of origin firing within S phase and can increase origin efficiency 
(30,36,139,140). In addition, histone H3 lysine 36 mono-methylation (H3K36me1) 
by the Set2 methyltransferase has been implicated in the recruitment of the 
replication initiation protein, Cdc45 (37,141). In metazoan genomes, Set8-
catalyzed histone H4 lysine 20 mono-methylation (H4K20me1) stimulates the 
loading of the core replicative helicase (112,127,140).  
It is clear that no single histone modification is absolutely required for 
origin function since loss of individual histone modifying enzymes does not 
impact cell viability. This observation suggests that a combination of histone 
modifications facilitate efficient DNA replication in the form of a “histone code” 
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similar to the combinations known to regulate transcription (5,142). While some 
elements of this code have been identified (e.g. H3 and H4 acetylation, H4K20 
monomethylation and H3K36 monomethylation), the complexity of DNA 
replication led us to hypothesize that additional histone modifications that impact 
origin activity remain to be discovered. We therefore sought to identify those 
histone modifications and chromatin modifiers that are integral to this process. 
We conducted a genetic screen to identify histone modifications that are required 
for the fitness of a hypomorphic replication yeast mutant, cdc6-1. This screen 
revealed a previously unidentified positive role for histone H3 lysine 4 (H3K4) 
methylation in DNA replication, and our subsequent analysis indicates that H3K4 
di-methylation is the relevant modification for this activity. These findings 
contribute to elucidating the pattern of chromatin features that determine origin 
activity in eukaryotic genomes. 
MATERIALS AND METHODS 
Yeast strains and growth conditions 
The Saccharomyces cerevisiae strains used in this study are listed in 
Table 2.1 and any additional genotype information is available upon request. 
Construction of de novo gene deletion strains was performed by PCR-mediated 
disruption, and some double mutant construction was performed by mating as 
indicated in Table 2.1. 
Plasmids 
All plasmids used in this study are listed in Table 2.2.  
Synthetic genetic array (SGA) screen 
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SGA analysis was carried out as previously described (141,143,144). Briefly, 63 
deletion strains (Table 2.3) were mated to the temperature-sensitive cdc6-1 
strain (JCY332) and haploids carrying both mutations were isolated by growth on 
selective media. All of the deletion strains originated from the Yeast Knock Out 
library (Open Biosystems) except strains lacking SET1 or DOT1; the set1Δ 
strains were created de novo while the dot1Δ strain had been previously 
published (134,145). Additionally, SET1 and BRE1 deletions were recreated de 
novo in the cdc6-1 mutant in the BY4741 background (yLF058). All of the 
resulting double mutants were spotted in 5-fold serial dilutions with an initial 
OD600 of 0.5 onto YPD, grown for 3 days at 32°C, and growth was compared to 
that of the cdc6-1 single mutant. Double mutants displaying a synthetic growth 
phenotype were confirmed by analyzing three independent isolates. The fold 
change in growth is denoted by a score from 1 to 3 indicating an approximate 5-
fold to 125-fold change compared to cdc6-1 alone. Negative values indicate 
growth defects, while positive values indicate enhanced growth or rescue. No 
genetic rescue was observed in any double mutant strain. 
Minichromosome maintenance assays 
Minichromosome (or plasmid) maintenance assays were performed as 
described previously (135,146,147). Briefly, yeast strains containing YCplac33, 
YCplac111, or YCplac33+2XARS209 were grown to log phase in the appropriate 
selective media and 100-200 cells were plated on both selective and non-
selective media to establish an initial percentage of plasmid-bearing cells. These 
cultures were also diluted to a concentration of 1 X 105 cells/ mL in 5 mL of non-
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selective media and grown for 8-10 generations before once again plating on 
both selective and non-selective media. Precise generation numbers were 
calculated using the following formula: n = log(CF/CI) / log(2), where CF 
represents the final number of cells as measured by OD600 and CI represents the 
starting cell number of 105 cells/mL. After 2 days of growth, colonies were 
counted and the plasmid loss rate (L) per generation (n) was calculated using the 
following formula:  L = 1-(%F / %I)(1/n), where %F is the final percentage of cells 
that retained the plasmid and %I is the initial percentage of cells that contain the 
plasmid. 
Immunoblotting 
Whole cell extracts were prepared by extraction with trichloroacetic acid 
(TCA). Cell growth was halted by the addition of TCA to a final concentration of 
5% and the cell pellets were frozen at -80°C. Pellets were resuspended in 200 µL 
TCA buffer (10 mM Tris-HCl, pH 8.0, 10% TCA, 25 mM NH4OAc, 1 mM EDTA) 
and broken by glass bead lysis. Proteins were precipitated by centrifugation, 
resuspended in 100 µL resuspension buffer (0.1 M Tris-HCl, pH 11.0, 3% SDS), 
and boiled for 5 min. Samples were centrifuged, and the supernatant was 
quantified using the Dc Assay (BioRad). Equal concentrations of lysates were 
loaded onto 15% SDS-PAGE gels and transferred onto PVDF. The following 
antibodies were used: anti-H3 (1:10,000; ActiveMotif 39163), anti-H3K4me1 
(1:2000; Millipore 07-436), anti-H3K4me2 (1:2000; abcam 32356), anti-H3K4me3 
(1:10,000; gift from M. Bedford), anti-H2B (1:5000; ActiveMotif 39237), anti-Myc 
(9E10; 1:1000; Santa cruz sc-40), and anti-LexA (1:5000; Millipore 06-719). 
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Chromatin immunoprecipitation 
Yeast strains were crosslinked with 1% formaldehyde for 15 min at RT 
and quenched with 250 mM glycine for 5 min at RT. Forty OD600 units of 
crosslinked cells were harvested by centrifugation, washed thoroughly, and the 
pellets were stored at -80°C. The cell pellets were resuspended in 300 mM FA-
lysis buffer (50 mM HEPES-KOH, pH 7.5, 300 mM NaCl, 1 mM EDTA, 1% 
TritonX-100, 0.1% Na-deoxycholate) with protease inhibitors, broken by glass 
bead lysis, and fixed chromatin was sheared by sonication using a Branson 
sonifier 250. Average DNA fragment lengths were 100-300 bp determined by gel 
analysis. After centrifugation and quantification via Bradford Assay (BioRad), 0.5 
mg of soluble chromatin was incubated with 2 µL of antibody (anti-H3 
(ActiveMotif), anti-H3K4me2 (Abcam) or anti-H3K4me3 (Millipore)) in 1.5 mL 
tubes overnight at 4°C and immunoprecipitated with 10 µL Protein A Dynabeads 
(Invitrogen) for 1 h at 4°C. The beads were washed sequentially with 300 mM 
FA-lysis buffer, twice with 500 mM FA-lysis buffer (50 mM HEPES-KOH, pH 7.5, 
500 mM NaCl, 1 mM EDTA, 1% TritonX-100, 0.1% Na-deoxycholate), once with 
LiCl solution (10 mM Tris-HCl, pH 8.0, 250 mM LiCl, 0.5% NP-40, 0.5% Na-
deoxycholate, 1 mM EDTA), and once with TE, pH 8.0. After washing, the 
chromatin was eluted from the beads in 200 µL elution buffer (0.1 M NaHCO3, 
1% SDS) for 30 min at RT. The eluted material was treated with RNAse A and 
Proteinase K before de-crosslinking at 65°C overnight. The DNA was purified 
using Genesee UPrep spin columns and eluted in 100 µL water. IP samples and 
IP controls (set1Δ) were used undiluted while input samples were diluted 1:10. 
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Samples were analyzed by qPCR on the ABI 7900 HT (AppliedBiosystems) 
using SYBR Green master mix with Rox (Fermentas). Primer sequences are 
available upon request. Signals from the immunoprecipitates are reported as a 
percentage of the input and normalized to H3. Error bars represent the standard 
deviations of the average signals between experiments (n ≥ 3).   
RESULTS 
Identification of histone modifiers that promote DNA replication  
DNA replication origins in the budding yeast Saccharomyces cerevisiae 
are defined by both sequence elements and local chromatin structure. Although 
DNA replication is essential for cell proliferation, the majority of histone 
modifications and chromatin-modifying enzymes are not individually required for 
yeast cell viability. This observation supports the model that a combination of 
histone modifications supports replication origin function. To identify new histone 
modifications that contribute to this combination, we conducted a genetic screen. 
We reasoned that individual chromatin elements that influence replication activity 
would be revealed as genetic suppressors or enhancers of cell growth in a strain 
bearing a hypomorphic mutation in an essential replication gene, CDC6.  
 The Cdc6 ATPase plays an essential role at origins in loading the 
replicative helicase complex composed of MCM2-7 (6,137,148). The cdc6-1 
mutant harbors a G260D mutation in the catalytic domain resulting in failure to 
load MCMs at restrictive temperatures (139,147). Yeast cells harboring the cdc6-
1 mutation produce a Cdc6 protein that functions normally at 29°C, is 
nonfunctional at temperatures above 34°C, but retains partial function at 
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intermediate temperatures between 30°C and 33°C (139,149). To identify 
suppressors or enhancers of cdc6-1, we deleted most of the known histone 
modifiers, chromatin remodelers, and histone chaperones (63 total; see Table 
2.3) in the cdc6-1 temperature-sensitive replication mutant strain. Double mutant 
strains were tested for fitness at semi-permissive temperatures and compared to 
the parent single mutant strains (141,150). The majority of double mutant strains 
grew neither better nor worse than their respective parents under any of the 
tested growth conditions, and no null alleles improved the growth of the cdc6-1 
mutant (Table 2.3). Although a role for the HAT Gcn5 in DNA replication has 
been shown (37,140,151,152), it was not included in this screen because the null 
mutant strain has a slow growth phenotype that would complicate interpretation 
of the double mutant phenotype. In contrast, 21 of the null alleles (including a 
positive control tom1Δ) impaired growth in the cdc6-1 strain but had little effect in 
otherwise wild-type backgrounds. These genes represent a wide array of 
chromatin factors including histone acetyltransferases (HATs), histone 
deacetylases (HDACs) and histone methyltransferases (HMTs) (Table 2.3). 
Interestingly, many of these factors contributed either directly or indirectly to a 
single histone modification, H3K4 methylation, which is deposited by Set1, the 
catalytic subunit of the COMPASS complex (Figure 2.1A).  
COMPASS activity and H3K4 methylation promote DNA replication 
We confirmed the enhancer phenotype of the SET1 deletion strain by 
constructing a set1Δ allele de novo in the cdc6-1 parent strain. Growth of the 
cdc6-1 strain was only slightly impaired at 31°C compared to wild-type or the 
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Table 2.3 Results from SGA screen for genetic interaction with cdc6-1 
DELETION SCOREa FUNCTION/COMPLEX 
bre1b,c -3 E3 ubiquitin ligase 
chd1b -3 Remodeler/SAGA 
rad6b,c -3 E2 ubiquitin-conjugating enzyme 
spt8b -3 SAGA HAT 
bre2b,c -2 COMPASS 
cdc73b -2 Paf1C 
hst1b -2 HDAC 
hst3b -2 HDAC 
isw1b -2 Remodeler 
rph1b -2 H3K36 DMT 
rtf1b -2 Paf1C 
sap30b -2 HDAC 
set1b,c -2 H3K4 HMT 
swd1b,c -2 COMPASS 
swd3b,c -2 COMPASS 
tom1 -2 E3 ubiquitin ligase/Positive Control 
ctk1 -1 Kinase  
hat1 -1 HAT 
hda1 -1 HDAC 
sdc1b,c -1 COMPASS 
snf5 -1 Remodeler 
asf1  0 Histone Chaperone 
dot1b,c  0 H3K79 HMT 
eaf1  0 NuA4 HAT 
eaf3  0 NuA4 HAT 
eaf6  0 NuA3/4 HAT 
ecm5  0 JmjC DMT 
gis1  0 JmjC DMT 
hap2  0 Elongator HAT 
hir1  0 Remodeler 
hir2  0 Remodeler 
hir3  0 Remodeler 
HO  0 Endonuclease/Negative Control 
hos1  0 HDAC 
hos2  0 HDAC 
jhd1  0 H3K36 DMT 
jhd2  0 H3K4 DMT 
nto1  0 NuA3 HAT 
rco1  0 Rpd3(S) HDAC 
rpd3  0 Rpd3(S)/(L) HDAC 
rtt102  0 Remodeler 
rtt109  0 H3K56 HAT 
rub1  0 Ubiquitin-like 
sas2  0 SAS HAT 
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Table 2.3 Results from SGA screen for genetic interaction with cdc6-1 
(continued) 
 
DELETION SCOREa FUNCTION/COMPLEX 
sas3 0 NuA3 HAT 
sds3 0 Rpd3(L) HDAC 
set2 0 H3K36 HMT 
sgf73 0 SAGA HAT 
shg1b,c 0 COMPASS 
snf1 0 Kinase  
snf6 0 Remodeler 
spp1b,c 0 COMPASS 
sps1 0 Kinase  
spt5 0 PolII Associated 
spt7 0 SAGA HAT 
ste20 0 Kinase  
swi2/snf2 0 Remodeler 
swr1 0 Remodeler 
tel1 0 Repair 
a
Score represents change in growth corresponding to approximate 5-fold 
differences (1=5-fold, 2=25-fold, etc.) 
bStrains in a YMS196 cdc6-1 background confirmed in three independent isolates
 
c
Strains created de novo 
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cdc6-1 strain harboring wild-type CDC6 on a plasmid, but growth was 
substantially impaired when SET1 was deleted in this strain (Figure 2.1B). 
Expression of wild-type SET1, but not the catalytically dead mutant set1-H1017K, 
rescued the synthetic growth defect of the set1Δ cdc6-1 strain (Figure 2.1B). 
Importantly, the synthetic growth defect of the set1Δ cdc6-1 strain was 
recapitulated in a cdc6-1 strain in which the only copy of histone H3 bears the 
K4R (unmethylatable) mutation (Figure 2.1C). These findings indicate that the 
catalytic activity of Set1 is important for robust growth of the cdc6-1 replication 
mutant.  
Set1 functions as the catalytic subunit of the COMPASS complex. We 
hypothesized that other members of this complex would display similar 
phenotypes when deleted in the cdc6-1 strain. Deletion of BRE2, SDC1, SWD1, 
and SWD3 each impaired the growth of the cdc6-1 mutant at semi-permissive 
temperatures, but not deletion of SPP1 or SHG1 (Figure 2.1D and Table 2.3). 
Bre2, Sdc1, Swd1, Swd2, and Swd3 (along with Set1) are the core structural 
components of the COMPASS complex required for full activity (142,153,154). 
These results further support the conclusion that COMPASS enzymatic activity 
and H3K4 methylation are important for proliferation when Cdc6 is crippled.  
The poor growth of these double mutant strains could be due to a general 
exacerbation of the replication defect caused by Cdc6 perturbation, or it could 
reflect a specific interaction between Cdc6 and H3K4 methylation. If Set1 and 
H3K4 methylation are generally important for efficient DNA replication, then we 
expect similar proliferation defects from deleting SET1 in other replication mutant 
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FIGURE 2.1.  COMPASS and H3K4 are required for robust growth of the 
temperature-sensitive cdc6-1 replication mutant. A) COMPASS complex 
model adapted from (142). (* denotes complex member that genetically interacts 
with cdc6-1) B) Wild-type (BY4741), cdc6-1 (yLF058), set1Δ (yLF062), and cdc6-
1 set1Δ (yLF063) were transformed with an empty vector [pGLx2], a vector 
producing LexA-tagged wild-type Set1 [pGLx2-SET1], or catalytically dead Set1 
[pGLx2-set1-H1017K], from a GAL1 promoter construct, or a vector producing 
normal Cdc6 [pRS316-CDC6], from the CDC6 promoter as indicated. Five-fold 
serial dilutions were spotted onto SC-URA containing 1% galactose/2% raffinose 
and grown at the indicated temperatures for 4 days. C) The cdc6-1 mutation was 
introduced into the H3-H4 “shuffle” strain (DY7803) transformed with HHT2 or 
hht2-K4R plasmids. Five-fold serial dilutions were spotted onto YPD and grown 
at the indicated temperatures for 3 days. D) Five-fold serial dilutions of wild-type 
(YMS196), cdc6-1 (JCY332), cdc6-1 swd1Δ (yLF036), cdc6-1 bre2Δ (yLF037), 
bre2Δ (yLF060), or swd1Δ (yLF061) were spotted onto YPD and grown at the 
indicated temperatures for 3 days. 
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strains. To test this prediction, SET1 was deleted in two temperature-sensitive 
cdc7 mutants and one temperature-sensitive cdc45 mutant. These replication 
factors function at the origin firing step at the G1/S transition, downstream of 
Cdc6 activity (142-144). Similar to the effect of deleting SET1 in the cdc6-1 strain, 
loss of SET1 in the cdc7-1, cdc7-4, and cdc45-27 mutants impaired growth at 
semi-permissive temperatures (Figure 2.2A). In addition, cells lacking SET1 were 
also sensitive to pharmacological replication stress induced by hydroxyurea (HU) 
(Figure 2.2C). 
The poor growth of cdc6-1 set1Δ cells suggests that Set1 promotes 
replication; we thus predicted that loss of H3K4 methylation in a hypermorphic 
replication mutant would at least partially rescue the adverse phenotypes of that 
mutant. To test this hypothesis, we introduced the set1 null allele into the 
hypermorphic replication mutant, RUY028. This yeast strain harbors two 
mutations that de-regulate replication origin licensing resulting in re-replication, 
an aberrant phenomenon in which some origins fire more than once per cell 
cycle leading to DNA damage and poor cell growth. The ORC6-rxl mutation 
prevents inhibitory phosphorylation of the Orc6 subunit of the Origin Recognition 
Complex (ORC) by CDK, and the GAL1 pr-CDC6-ΔNT allele produces a 
hyperstable Cdc6 protein (145,155). In this strain, re-replication is induced during 
growth on galactose, which induces transcription of the CDC6-ΔNT allele. As 
expected, loss of H3K4 methylation upon deletion of SWD1 or BRE1 partially 
rescues the poor growth of the re-replicating strain on galactose (Figure 2.2B).  
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FIGURE 2.2. H3K4 methylation is required for robust growth of multiple 
replication mutants. A) Five-fold serial dilutions of the meiotic progeny from the 
cross of cdc7-1 (TSQ880), cdc7-4 (TSQ131), or cdc45-27 (TSQ694) with set1Δ 
(yLF062) were spotted onto YPD and grown at the indicated temperatures for 3 
days. B) Five-fold serial dilutions of wild-type (RUY121), ORC6-rxl CDC6-ΔNT 
(RUY028), swd1Δ (yLF051), and ORC6-rxl CDC6-ΔNT swd1Δ (yLF049) were 
spotted onto YP containing 2% dextrose (no re-replication) or galactose (re-
replication induced) and grown for 2 days at 30°C. C) Five-fold serial dilutions of 
wild-type (BY4741) or set1Δ (yLF062) were spotted on YPD containing the 
indicated concentrations of HU and grown for 2 days at 30°C. 
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Together, these data provide strong evidence that H3K4 methylation promotes 
efficient DNA replication, most likely through regulation of origin activity.  
A positive role for H3K4 methylation in replication suggests that this 
histone modification is enriched near origins of replication. To test this idea 
directly, we performed chromatin immunoprecipitation (ChIP) assays for both di- 
and tri-methylated H3K4 in asynchronous wild-type yeast cultures. Analysis of 
several genomic loci revealed that both H3K4 methylation states are enriched at 
both an early-and late-firing origin of replication (ARS315 and ARS822, 
respectively) relative to a non-origin, telomere-proximal region (Figure 2.3A and 
B). In addition, if Set1 activity were important for origin licensing during G1, we 
would expect Set1 protein levels to be high during this cell cycle phase. Cells 
expressing a 3XMyc-tagged Set1 were arrested in G1 using alpha factor and 
samples were taken at the indicated times after release (Figure 2.3C). 
Surprisingly, Set1 was only detectable during G1 supporting a role for this HMT 
in promoting origin licensing. 
The Rad6/Bre1 ubiquitin ligase complex promotes DNA replication  
Methylation of histone H3K4 by the COMPASS complex requires prior 
monoubiquitination of histone H2B at lysine 123 (H2BK123) by the Rad6/Bre1 
ubiquitin E3 ligase (146,147,153). Our original screen detected a strong synthetic 
growth defect when the bre1Δ library mutant was crossed with the cdc6-1 parent 
strain. De novo deletion of either BRE1 or RAD6 in the cdc6-1 mutant resulted in 
an approximate 125-fold decrease in growth at semi-permissive temperatures, 
validating this genetic interaction (Figures 2.4A and B). Ectopic expression of 
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FIGURE 2.3. H3K4 methylation is present at replication origins and Set1 is 
most abundant during G1. Chromatin immunoprecipitation (ChIP) experiments 
were performed on asynchronous wild-type (BY4741) or set1Δ (yLF062) strains 
grown at 30°C. Immunoprecipitates using antibodies to total histone H3, di-
methylated H3K4 (H3K4me2) in A and tri-methylated H3K4 (H3K4me3) in B were 
analyzed by quantitative PCR for chromosomal DNA fragments from a region 
near telomere VI-R and two replication origins, ARS315 and ARS822. Error bars 
represent the standard deviations of n > 3 biological replicates. Significant 
enrichment of H3K4 methylation at origins compared to telomere VI-R was 
determined by Student’s unpaired t-test. (*p<0.05) C) Wild-type (BY4741) yeast 
strains expressing 3XMyc-tagged Set1 were synchronized in G1 and cells were 
harvested at the indicated times after alpha factor release. 
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wild-type BRE1 under control of its own transcriptional promoter fully rescued the 
exacerbated growth phenotype, but expression of a catalytically dead Bre1 (bre1-
H665A) did not (Figure 2.4A). Moreover, BRE1 deletion also partially rescued the 
growth impairment of the re-replicating RUY028 strain similar to what was 
observed after SET1 deletion (Figure 2.4C). These data suggest that the 
Rad6/Bre1 ubiquitin ligase complex is also required for efficient DNA replication, 
likely through its involvement in promoting H3K4 methylation.  
H3K4 methylation is required for efficient minichromosome maintenance  
To assess DNA replication more specifically than general cell proliferation, 
we used a plasmid loss assay that measures the ability of cells to maintain a 
minichromosome bearing a centromere and a single replication origin (148,153). 
Growth in non-selective medium for several cell divisions allows cells that failed 
to initiate replication of the minichromosome to survive, and these cells are then 
counted as colonies on non-selective medium. Strains lacking either SET1 or 
BRE1 displayed significantly higher plasmid loss rates per cell division than wild-
type strains did (Figure 2.5A, p<0.05). Similar to the phenotype resulting from 
SET1 deletion, cells expressing the mutant histone H3K4R displayed a 
significant increase in plasmid loss rate (Figure 2.5B).  
 Of note, H2B monoubiquitination by Rad6/Bre1 is not only a pre-requisite 
for H3K4 methylation, but also for H3K79 methylation (147,153). Neither deletion 
of DOT1, the histone H3K79 methyltransferase, nor mutation of H3K79 to 
arginine had any effect on plasmid maintenance (Figure 2.5A and B). Moreover,  
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FIGURE 2.4. H2BK123 mono-ubiquitination promotes robust growth of the 
temperature-sensitive cdc6-1 replication mutant. A) Wild-type (BY4741), 
bre1Δ (yLF151), cdc6-1 (yLF058), and cdc6-1 bre1Δ (yLF150) were transformed 
with either an empty vector [pRS315], a vector expressing BRE1 (pRS315-
9xMyc-BRE1), or bre1-H665A (pRS315-9xMyc-bre1-H665A) from the native 
BRE1 promoter. Five-fold serial dilutions were spotted onto SCD-LEU and grown 
for 4 days at the indicated temperatures. B) Five-fold serial dilutions of wild-type 
(YMS196), cdc6-1 (JCY332), rad6Δ (yLF154), and cdc6-1 rad6Δ (yLF117) were 
spotted onto YPD and grown for 3 days at the indicated temperatures. 
C) Wild-type (RUY121), ORC6-rxl CDC6-ΔNT (RUY028), bre1Δ (yLF052), and 
ORC6-rxl CDC6-ΔNT bre1Δ (yLF050) were spotted onto YP containing 2% 
dextrose or 1% galactose (re-replication induced) and grown for 3 days at 30°C.  
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loss of Dot1 did not impair the growth of the cdc6-1 strain (Table 2.3). Efficient 
growth and plasmid maintenance by these strains indicate that the elevated 
plasmid loss rate of the BRE1 null strain is likely due to the subsequent loss of 
H3K4 methylation rather than loss of H3K79 methylation. Further, these results 
demonstrate that inefficient minichromosome maintenance is not a universal 
phenotype of strains lacking histone-modifying enzymes or expressing mutant 
histones.  
If these minichromosome maintenance defects are specific to 
perturbations of origin function and not chromosome segregation or expression 
of the selectable marker, then adding multiple origins to the test plasmid should 
rescue the elevated loss rates of the set1Δ and bre1Δ strains. Additional origins 
multiply the chances for a successful origin initiation event on the plasmid, and 
success at any one origin allows replication and transmission to both daughter 
cells. This property has been used by others to validate origin-specific 
phenotypes (149,156). We modified the single ARS1-containing plasmid by 
adding two copies of ARS209. As before, the plasmid harboring only one origin 
was lost more frequently from set1Δ and bre1Δ strains than from wild-type strains, 
but this effect was reversed with the addition of multiple origins (Figure 2.5C). 
This result supports the conclusion that H2BK123 monoubiquitination by Bre1 
and the consequent H3K4 methylation by Set1 promote DNA replication origin 
function in yeast.  
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FIGURE 2.5. H3K4 methylation is required for efficient origin-dependent 
minichromosome maintenance. A) Plasmid loss rates of a single origin bearing 
plasmid  [YCpLac33] were measured in a wild-type strain (BY4741) and strains 
lacking SET1 (yLF089), BRE1 (yLF151), or DOT1 (YNL037). Loss rates are 
reported per cell division. B) Plasmid loss rates of a single origin bearing plasmid 
[YCpLac111] were measured in the histone “shuffle” strain (DY7803) transformed 
with plasmids expressing wild-type HHT2, hht2-K4R, or hht2-K79R. C) Plasmid 
loss rates of plasmids bearing either a single origin [YCpLac33] or three origins 
[YCpLac33 + 2X ARS209] were measured. For all experiments, the average loss 
rates were obtained from at least three independent transformants, and the error 
bars indicate standard deviations. Statistics were performed using the Student’s 
unpaired t-test. (*p<0.05) 
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H3K4 di-methylation is required for efficient origin function 
The Set1/COMPASS complex is responsible for mono-, di-, and tri-
methylation of H3K4. These methylation states are differentially distributed over 
gene bodies (150,157,158) and several studies have shown that different  
methylation states of H3K4 and H3K36 can have different functions 
(37,151,152,159). The individual H3K4 methylation states depend on other 
histone residues and are influenced by the presence or absence of individual 
COMPASS subunits (153,154,160). To gain insight into which H3K4 methylation 
states were required for efficient DNA replication, we measured plasmid loss 
rates in strains lacking different COMPASS complex members. Like the set1Δ 
strain (Figure 2.5A) both swd1Δ and bre2Δ strains displayed significantly 
elevated plasmid loss compared to their isogenic wild-type counterparts (Figure 
2.6A). These two proteins are both required for Set1 stability (142,161), and in 
their absence no H3K4 methylation is detectable (Figure 2.6B). Unlike Swd1 and 
Bre2, Spp1 is a COMPASS subunit that is required for H3K4 tri-methylation, but 
not mono- or di-methylation (Figure 2.6B) (5,155,162); loss of SPP1 had no 
effect on plasmid maintenance (Figure 2.6A). This result is consistent with our 
earlier observation that Spp1 loss did not affect proliferation of the cdc6-1 strain 
(Table 2.3). Taken together, these data suggest that H3K4 di-methylation is 
sufficient for proper origin function and that H3K4 tri-methylation is dispensable.  
 To examine the role of H3K4 di-methylation without perturbing the 
COMPASS complex, we took advantage of H2B mutants that were previously 
shown to differentially affect H3K4 methylation (92,153,163,164). Mutation of 
	   55	  
H2BK123 to arginine abolished monoubiquitination of this residue and 
consequently eliminated both H3K4 di- and tri-methylation (Figure 2.6D). 
Importantly, similar to loss of BRE1, this mutation induced a significantly higher 
plasmid loss rate than wild-type (Figure 2.6C). This result, in combination with 
the failure of the Bre1 catalytically dead mutant to complement the growth defect 
of the bre1Δ cdc6-1 mutant, strongly argues that the H2BK123 ubiquitination 
function of Bre1 is required for full origin function. Additionally, it supports the 
importance of H3K4 di-methylation in this process. 
A previous study reported that mutational alteration of H2BR119 to alanine 
does not prevent H2BK123 monoubiquitination, but does affect the degree of 
H3K4 methylation (37,153). As previously reported, changing H2BR119 to 
alanine (H2BR119A) reduces the chromatin association of Spp1 and therefore 
H3K4 tri-methylation, whereas changing H2BR119 to aspartic acid (H2BR119D) 
results in loss of H3K4 di- and tri-methylation to the same extent as eliminating 
H2BK123 monoubiquitination (23,153). Our analysis of these histone H2B 
mutants revealed that strains expressing htb1-R119D displayed elevated plasmid 
loss rates similar to those of the htb1-K123R strain (Figure 2.6C). Mutation of 
R119 to alanine abolished H3K4 tri-methylation as expected, while having only a 
moderate effect on H3K4 di-methylation (Figure 2.6D). This H2B mutant showed 
a plasmid loss rate similar to the wild-type HTB1 strain. The strict correlation 
between the ability to produce H3K4 di-methylation and normal plasmid 
maintenance underscores the importance of H3K4 di-methylation, but not 
necessarily H3K4 tri-methylation, for origin function (Figure 2.6C).  
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FIGURE 2.6. H3K4 di-methylation promotes efficient minichromosome 
maintenance. A) Plasmid loss rates of the single origin bearing plasmid 
[YCpLac33] were measured for wild-type (BY4741), swd1Δ (yLF061), bre2Δ 
(yLF060), and spp1Δ (yLF153). B) Immunoblot analysis of whole cell extracts 
(from strains shown in A) using antibodies to total H3, H3K4me1, H3K4me2, and 
H3K4me3. C) Plasmid loss rates of the single origin bearing plasmid 
[YCpLac111] were measured for the H2B” shuffle” strain (FY406) transformed 
with plasmids expressing HTB1 [pZS145], htb1-K123R [pZS146], htb1-R119D 
[pZS473], or htb1-R119A [pZS145-R119A]. D) Immunoblot analysis of whole cell 
extracts (from strains shown in C) using antibodies specific for total H2B, H3, and 
H3K4 methylation as in B. All plasmid loss data represent the mean and standard 
deviation of at least three independent transformants. Statistics were performed 
using the Student’s unpaired t-test. (*p<0.05) 
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 Our initial observation that loss of SET1 in a cdc6-1 mutant strain resulted 
in a proliferation defect, coupled with the requirement for Set1 for proper 
minichromosome maintenance, clearly indicates that H3K4 methylation is 
necessary for robust DNA replication. To determine if H3K4 di-methylation is 
sufficient for DNA replication, we transformed the cdc6-1 set1Δ strain with 
plasmids directing the production of wild-type Set1, catalytically dead Set1 
(Set1H1017K), or a Set1 protein lacking the RRM domain. The latter mutant can 
only di-methylate H3K4 (29,156,165). Each of these Set1 proteins was fused to a 
LexA tag for detection on immunoblots (Figure 2.7B) and expressed from the 
GAL1 promoter on galactose-containing medium. Immunoblot analysis of the 
three H3K4 methylation states confirmed that the fusions generated the expected 
methylation states (Figure 2.7B). As before, production of active Set1 
suppressed the growth phenotype caused by deleting SET1 in the cdc6-1 strain 
(Figure 2.7A). Importantly, production of Set1ΔRRM also fully rescued this 
proliferation defect without the ability to produce H3K4 tri-methylation (Figure 
2.7B). These data demonstrate that H3K4 di-methylation is both necessary and 
sufficient for robust growth of the cdc6-1 mutant and suggest that this histone 
modification plays an important positive role in origin function. 
DISCUSSION 
This study documents a novel role for H3K4 di-methylation in DNA 
replication origin function. Yeast strains with hypomorphic mutations in multiple 
replication genes are highly dependent on H3K4 di-methylation for robust growth. 
In these replication mutants (cdc6-1, cdc7-1, cdc7-4, cdc45-27) under semi-  
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FIGURE 2.7. H3K4 di-methylation is sufficient for robust growth of the 
cdc6-1 mutant. A) Wild-type (BY4741), cdc6-1 (yLF058), set1Δ (yLF062), and 
cdc6-1 set1Δ (yLF063) were transformed with an empty vector [pGLx2], a vector 
producing LexA-tagged wild-type Set1 [pGLx2-SET1], or Set1 lacking the RRM 
domain [pGLx2-set1-ΔRRM] from the GAL1 promoter. Five-fold serial dilutions 
were spotted onto SC-URA containing 1% galactose and grown at the indicated 
temperatures for 5 days. B) Immunoblot analysis of whole cell extracts from 
either wild-type (BY4741) or set1Δ (yLF062) strains transformed with empty 
vector [pGLx2] or vectors producing LexA-tagged normal (“WT”) Set1 [pGLx2-
SET1], catalytically dead (“CD”) Set1 [pGLx2-set1-H1017K], or Set1 lacking the 
RRM domain (“RRM”) [pGLx2-set1-ΔRRM] from the GAL1 promoter. Blots were 
probed with antibodies specific for LexA, total H3, H3K4me3, H3K4me2, and 
H3K4me1 (* represents a likely degradation product unique to the positive control 
construct; ** represents a non-specific band detected by the H3K4me1 antibody).  
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permissive conditions, replication activity is reduced to the minimum needed for 
normal growth, and any further reduction in active origins caused by loss of H3K4 
di-methylation results in severely impaired proliferation. Additionally, normal 
propagation of a minichromosome containing a single origin requires H3K4 di-
methylation even in an otherwise wild-type strain. Every mutation that prevents 
H3K4 di-methylation, including loss of the pre-requisite histone H2BK123 
monoubiquitination, causes a similar replication phenotype. These data provide 
clear evidence that H3K4 di-methylation is important for full origin function.  
The Set1 histone methyltransferase and the Bre1 ubiquitin E3 ligase have 
well-established roles in regulating gene expression (157,158,166). Nonetheless, 
several lines of evidence suggest that the phenotypes we have detected are due 
to faulty replication as opposed to altered gene expression. First, many 
chromatin-modifying enzymes showed no synthetic growth phenotype when 
combined with the cdc6-1 mutation. Some of these non-interacting genes include 
those with much more profound effects on patterns of gene expression than Set1, 
suggesting that replication phenotypes are not a general outcome of perturbed 
gene expression control. Interestingly, even the Rpd3 histone deacetylase that 
regulates origin firing time within S phase (159,167) did not genetically interact 
with cdc6-1 (Table 2.3), implying that the synthetic growth phenotypes observed 
here are relatively specific for origin function and not origin timing.  Second, a 
genome-wide analysis identified only 55 transcripts that changed significantly in a 
set1Δ strain compared to a wild-type strain, and none of those genes are 
predicted to directly affect origin activity (160,168). Third, the mini-
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maintenance phenotypes associated with loss of H3K4 di-methylation were 
largely suppressed by the addition of extra origins to the test plasmid, indicating 
that the phenotypes are closely tied to origin function and not other biological 
parameters. Fourth, we directly detected H3K4 di- and tri-methylation at two 
yeast origins. Moreover, our analysis of a published genome-wide H3K4 tri-
methylation dataset identified peaks of methylation distinct from nearby 
transcription-associated peaks (161,169, and our unpublished observations). 
Finally, our observation that loss of H3K4 methylation exacerbates poor growth 
of a replication hypomorphic strain but suppresses the poor growth of an origin 
firing hypermorphic strain indicates that the replication phenotypes reported here 
are most likely direct positive effects of H3K4 di-methylation at origins. Taken 
together, these data provide strong evidence that the role of H3K4 di-methylation 
in origin function is direct and separate from any indirect transcriptional effects.  
 DNA replication is an essential process for proliferation, yet neither Set1 
nor Bre1 are essential gene products. Interestingly, very few null mutations in 
yeast chromatin-modifying enzymes show significant growth defects despite their 
importance for several essential processes, such as transcription, replication, 
and repair. The function of histone modifications in transcriptional control has 
been described as a “histone code” in which combinations of post-translational 
modifications promote or repress transcription at a given locus (5,151,162,170-
172). In this model, no single histone modification generates an active or inactive 
promoter, and thus the effects of mutations that alter local chromatin structure 
are cumulative. We propose that the same concept applies to chromatin structure 
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at DNA replication origins. Consistent with the idea that, like promoters, origins 
can accommodate elimination of a single positive element of chromatin structure, 
the kinetics of S phase progression are normal in a set1Δ strain grown in 
standard conditions (data not shown). Also analogous to transcriptional control at 
promoters, we propose that histone H3K4 di-methylation is an important element 
of origin chromatin structure, but its absence alone does not severely inhibit 
origin function. In fact, origin activity is robust enough that even substantial 
reductions in expression of MCM proteins or deletion of many origins from a 
yeast chromosome causes no growth defects (37,92,163,164). Nevertheless, the 
effect of H3K4 di-methylation loss over several cell cycles or in combination with 
other replication perturbations causes a significant loss of replication fitness.  
 How does H3K4 di-methylation promote DNA replication? We propose two 
models by which H3K4 di-methylation could facilitate DNA replication (Figure 2.8). 
The first is a recruitment model whereby a replication factor directly interacts with 
di-methylated H3K4 to associate with replication origins. This possibility is 
supported by precedent since it has previously been suggested that mono-
methylation of H3K36 can recruit the replication initiation factor, Cdc45 (37,173). 
In addition, a member of the origin recognition complex, Orc1, contains a bromo-
adjacent homology (BAH) domain that mediates nucleosome binding; this 
domain is known to be important for the association of ORC with origins (23,30). 
Therefore, domains in other replication factors may bind to nucleosomes or 
specific histone modifications, or as yet unidentified bridging proteins could link 
H3K4 di-methylation to recruitment of the core replication machinery at origins. 
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Illuminating the molecular mechanism(s) by which H3K4 di-methylation is 
connected to replication proteins at origins will require additional studies.  
 The second model suggests that H3K4 di-methylation near the origin 
recruits another chromatin modifier such as a histone acetyltransferase (HAT). 
The HAT could then acetylate nearby nucleosomes, resulting in increased 
accessibility to the origin to allow more efficient association of replication factors 
(Figure 8).  Acetylation is already known to affect the efficiency and timing of 
origin firing (29,165). Additionally, several HAT complexes contain subunits that 
specifically recognize H3K4 methylation. The HAT complex SAGA contains the 
catalytic subunit Gcn5 as well as two proteins, Chd1 and Spt8, that genetically 
interact with cdc6-1 (Table 2.3). Chd1 is a chromatin remodeler whose 
mammalian counterpart is capable of binding H3K4 methylation (166) while Spt8 
impacts transcription by directly recruiting TBP (167). SAGA also contains the 
Sgf29 subunit that has recently been reported to bind di- and tri-methylated H3K4 
to facilitate SAGA recruitment to some promoters (168). SAGA is responsible for 
acetylation of multiple H3 residues as well as H4K8 and H2BK11 and K16 (169). 
Two other HAT complexes were also identified in our screen, NuA3 and NuA4; 
both contain subunits that bind H3K4 methylation, Yng1 and Yng2, respectively 
(151,170-172). Further examination of these and other H3K4 methylation readers 
will shed light on the role of H3K4 methylation in the context of origin-specific 
chromatin. 
Prior research has identified other histone modifications that impact origin 
function. Mono-methylation of H3K36 by Set2 facilitates recruitment of the  
	   65	  
 
 
 
 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  	   	  	  	  	  	   	   	   	  	  	  	  	   	   	   	  	  	  	  	   	  	  	   	  	   	  	   	   	  	  	  	  	   	   	   	  	  	  	  	   	   	   	  	  	  	  	   	  	  	   	  	   	  	  	   	   	  	  	  	   	  	  	   	  	  	   	  	  	  	   	  	  	  	  	   	   	   	  	  	  	  	   	   	   	  	  	  	  	   	  	  	   	  	   	  	  
	   HAT 	   	  	  	  	  	   	   	   	  	  	  	  	   	   	   	  	  	  	  	   	  	  	   	  	   	  	   	   	  	  	  	  	   	   	   	  	  	  	  	   	   	   	  	  	  	  	   	  	  	   	  	   	  	  	  	   	   	   	   	   	   	  	  	  	  	   	   	   	  	  	  	  	   	  	  	   	  	  	   	   	  	  	  	   	  	  	   	  	  	   	  	  	  	   	   	   	  
Recruitment: 
Accessibility: 
	   	  	  	  	  	   	  	  	   	   	  	   	  	  	   	  	   	  Replication Factors H3K4me2 Acetylation 
Figure 2.8 
	   66	  
 
 
 
 
 
 
 
 
 
 
 
FIGURE 2.8. Two models by which H3K4 di-methylation could promote 
efficient DNA replication. The recruitment model suggests either direct or 
indirect recruitment of replication factors by H3K4 di-methylation, while the 
accessibility model suggests recruitment of a HAT that acetylates nucleosomes 
near the origin resulting in an open chromatin state that allows replication factors 
to access and bind the origin.  
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replication initiation factor, Cdc45 in yeast (37). In addition to methylation, H3K4 
can also be acetylated by both Gcn5 and Rtt109 (173). At promoters, this 
acetylation is typically found just upstream from the peak of H3K4 tri-methylation. 
Whether this modification is also found at origins is currently unknown. Multi-
acetylated histones H3 and H4 have been shown by several groups to impact the 
ability of origins to fire (30) and the timing of origin firing in yeast, Drosophila, and 
mammalian cells (16,24,29,174). Additionally, the HATs Hat1 and Gcn5 
physically interact with the replication machinery (136,140,175). In mammalian 
cells, Gcn5 acetylates Cdc6 at several lysine residues and this acetylation is 
required for subsequent phosphorylation by cyclin/CDKs (19,20,84,131,138). In 
vertebrates, the H4-specific HAT, HBO1, physically interacts with the replication 
machinery (2,73,74,100), and the acetylation of histones by HBO1 is essential for 
origin licensing (30,35,36,140). In metazoans, methylation of H4K20 by Set8 
(a.k.a. PR-Set7) is cell cycle regulated (37,112,176) and is required for proper S 
phase initiation and prevention of re-replication (112,127,177).  In S. cerevisiae 
histone H3 is phosphorylated at threonine 45 in a cell cycle-dependent manner 
by the Cdc7-Dbf4 kinase. Mutating this residue to alanine causes sensitivity to 
hydroxyurea and camptothecin indicating its importance in proper DNA 
replication (5,38). Because all organisms except S. cerevisiae lack common 
nucleotide sequence motifs at origins, discovering a chromatin signature that 
promotes origin function is essential to understand the location and activity of 
replication zones in higher eukaryotes. Given the complexity of metazoan 
genomes, it may be that several different chromatin signatures specify origins in 
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different chromosomal domains. Our discovery that H3K4 di-methylation is able 
to promote DNA replication adds to growing number of histone modifications that 
could function together to confer origin function at discrete genomic loci. Further 
work will determine which suite of histone modifications are common to all origins 
or are required only at specific genomic loci to successfully promote DNA 
replication.
  
 
 
  
 
CHAPTER 3 
 
Regulation of Set8 and Cdt1 by phosphorylation throughout the cell cycle 
 
INTRODUCTION 
 DNA replication is an essential cellular process that is highly regulated to 
maintain genome integrity. During G1, sites in the genome where replication 
initiates (origins of replication) are prepared or “licensed” for replication through 
formation of the preRC complex. The preRC complex consists of ORC, Cdc6, 
and Cdt1 that together recruit and load the replicative helicase of MCM proteins. 
Recently, the lysine methyltransferase Set8 was found to be a key factor 
promoting preRC formation (reviewed in reference 176). To prevent re-firing of 
origins, or rereplication, preRC formation must not occur outside of G1 phase. 
There are many mechanisms in place to restrict the activity of these proteins 
outside of G1; the most significant is the proteolytic degradation of the replication 
proteins Cdc6, Cdt1, and Set8.  
Both Cdt1 and Set8 are targeted for proteasomal degradation in S phase 
by the E3 ubiquitin ligase complexes, SCFSkp2 and CRL4Cdt2 (178). SCFSkp2 
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functions in S phase to inhibit spurious origin licensing through polyubiquitination 
of Cdt1 and Set8. SCFSkp2-dependent Cdt1 degradation requires prior 
phosphorylation of Cdt1 at T29 by Cyclin E/A-Cdk2 that facilitates association 
with Skp2 (178,179). A Cy-motif present in Cdt1 mediates its interaction with and 
phosphorylation by these Cyclin-CDK complexes (178). No similar mechanism 
regulating Set8 degradation by SCFSkp2 has been reported. 
CRL4Cdt2-mediated degradation of cell cycle regulators also ensures that 
replication occurs once and only once per cell cycle. The Cdt2 (Cdc10-
dependent transcript 2) substrate receptor is unique in that its interaction with 
substrates is dependent on the substrate first interacting with DNA-loaded PCNA. 
PCNA becomes loaded at replication forks during S phase and during the DNA 
synthesis steps of DNA repair (180-183). Proteins that interact with PCNA 
contain a motif known as a PCNA-interacting protein box (PIP box). CRL4Cdt2 
substrates contain a specialized PIP box known as the PIP degron. The PIP 
degron differs from the canonical PIP box in two ways. First, a TD motif is 
present within the PIP box that strengthens the interaction with PCNA (184-187). 
Second, the PIP degron contains a conserved basic residue located four amino 
acids downstream from the PIP box that is required for interaction with Cdt2 
(184,187,188). All bona fide substrates of CRL4Cdt2 contain this PIP degron. 
Interestingly, PCNA must be loaded onto chromatin to promote interaction 
between the substrate and Cdt2, though the basis for substrates to distinguish 
soluble PCNA from chromatin-loaded PCNA is not yet clear (187,189). Through 
the requirement for substrate interaction with PCNA, CRL4Cdt2-mediated 
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proteolysis is coupled to DNA replication during S phase and after DNA damage. 
Cdt1 harbors a PIP degron at its N-terminus through which it interacts with both 
Cdt2 and PCNA, while Set8’s PIP box is more centrally located. Failure to 
degrade either Cdt1 or Set8 at the onset of S phase results in multiple rounds of 
origin firing, or rereplication, that causes DNA damage and genome instability 
(112,122,179,190-195).  
Recently we have suggested that Cdt1 is phosphorylated by stress-
induced mitogen-activated protein kinases (MAPK) (104,196). Addition of cellular 
stressors, such as salt, lipopolysaccharide (LPS), or tumor necrosis factor alpha 
(TNF-α), activate the stress MAP kinases Jun N-terminal kinase (JNK) and p38 
(197). Our lab mapped five residues in the C-terminal third of Cdt1 that are 
phosphorylated by both JNK and p38 (196). Both the JNK and p38 stress MAP 
kinases phosphorylate these amino acids not only in response to exogenous 
stress, but also during unperturbed G2 and M phases when JNK and p38 are 
normally active. Phosphorylated Cdt1 is often detected as a slower-migrating 
isoform that is present during G2/M, cellular quiescence, or upon activation of 
stress MAPKs. However, phosphomimetic mutation of the five C-terminal 
phosphorylated residues of Cdt1 (Cdt12E3D) cannot complement knockdown of 
endogenous Cdt1 due to impaired MCM loading (196).  
Cdt1 is phosphorylated during mitosis and our lab has shown that Cdt1 is 
required at kinetochores for proper microtubule attachment (198). Cdt1 must be 
dephosphorylated upon mitotic exit to promote origin licensing during G1 
because C-terminal phosphorylation of Cdt1 impairs MCM loading (196). Another 
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phosphorylated residue also negatively impacts origin licensing. Cdt1 
phosphorylation at T29 by JNK impairs HBO1 association with replication origins 
(104). In contrast to T29 phosphorylation by Cdk2 (199), JNK-mediated 
phosphorylation of this site has no effect on Skp2 binding or Cdt1 stability (104). 
Our lab has shown that JNK phosphorylates at least five C-terminal residues, so 
perhaps these additional sites prevent association of Cdt1 with Skp2 leading to 
what appears to be two different effects of T29 phosphorylation. 
Set8 degradation is also influenced by phosphorylation. Set8 is 
phosphorylated by Cdk1 at S29 during mitosis, and phosphorylation at this site 
protects Set8 from APCCdh1-mediated proteolysis (123). This modification must 
be removed by the Cdc14 phosphatase to degrade Set8 and allow timely 
progression through mitosis (123). Whether this phosphorylation or novel 
phosphorylation sites also protect Set8 from CRL4Cdt2-mediated degradation is 
the focus of this study. 
Here, we investigate how CRL4Cdt2-mediated degradation of Cdt1 and 
Set8 is regulated in response to cellular stress and cell cycle position. We have 
observed that both Set8 and Cdt1 are protected from UV-induced degradation 
during a cellular stress response and distinct cell cycle phases. We will 
determine if phosphorylation of these substrates under these conditions is the 
mechanism preventing their degradation and identify the kinase(s) responsible. If 
phosphorylation is protective, does it prevent association of these substrates with 
the E3 ligase? If so, does this regulatory mechanism extend to all known 
CRL4Cdt2 substrates? Additionally, what are the biological consequences if this 
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protection is disrupted? We provide evidence that Cdt1 is protected from UV-
induced, Cdt2-dependent degradation during mitosis and cellular quiescence 
while Set8 is only protected during mitosis. Further, we show that protection 
during mitosis can be reversed upon inhibition of Cdk1. We continue to 
investigate the mechanism(s) and significance of this protection for maintaining 
genome integrity. 
MATERIALS AND METHODS 
 
Cell culture and manipulations 
 
HCT116, HeLa, T98G, and NHF-hTERT cells were cultured in Dulbecco 
modified Eagle medium (DMEM) (Difco) supplemented with 10% fetal calf serum 
(Sigma). Cells were synchronized in prometaphase by treatment with 2 mM 
thymidine for 18 h followed by release into 100 nM nocodazole for 10 h (or 12 h 
for T98G cells). T98G human glioblastoma cells were serum starved (DMEM 
only) for 48 h to promote cell cycle exit into quiescence (or G0). NHF cells were 
grown in DMEM supplemented with 0.05% serum for 72 h to promote cell cycle 
exit. Cellular stress was induced by the addition of 250 mM NaCl 15 min prior to 
induction of DNA damage either by UV irradiation (20 J/m2) or addition of 100 µM 
H2O2. MAP kinase inhibitors were used at the following concentrations: c-Jun N-
terminal kinase (JNK) inhibitor II (SP600125; 100 µM), JNK inhibitor VIII (10 µM), 
and p38 (SB203580; 30 µM). The Cdk1 inhibitor, RO-3306 (Sigma), was used at 
10 µM and the CDK inhibitor roscovitine was used at 25 µM. Cells were 
transfected with plasmids using 0.05% polyethylenimine (Sigma). Small 
interfering RNA (siRNA) transfections were performed with 100 nM each of 
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siRNA duplex using Dharmafect 1 reagent (Dharmacon) according to the 
manufacturer’s guidelines for depletion of luciferase (control) and p38α/β. JNK1/2 
siRNA was used at 250 nM. Synthetic duplexed RNA oligonucleotides were 
synthesized by Invitrogen; their sequences are provided in Table 3.1.  
Antibodies 
 
Antibodies were purchased from the following sources: p38, phospho-p38, 
Jun N-terminal kinase (JNK), phospho-JNK, MAPKAP kinase 2, phospho-
MAPKAP kinase 2, and Set8 from Cell Signaling Technologies; hemagglutinin  
(HA) from Roche; green fluorescence protein (GFP) (JL-8) from Clonetech; alpha 
tubulin (DM1A) from Sigma; Cdt2 antibody was a gift from A. Dutta. Antibodies to 
human Cdt1 have been previously described (49). 
Plasmids and protein lysate preparation 
Plasmids for transient transfection were generated by recombination (Gateway 
LR clonase; Invitrogen) of pENTR-Set8 derivatives with a Gateway-compatible 
pLX302 lentiviral vector. Whole-cell lysates were prepared in CSK buffer (200) 
(supplemented with protease and phosphatase inhibitors) and containing S7 
micrococcal nuclease and CaCl2 to release chromatin-bound material into the 
soluble pool and clarified by centrifugation. Whole-cell lysates were alternatively 
prepared by direct lysis of equal cell numbers in 2X Laemmli sample buffer with 
10% β-mercaptoethanol. 
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Table 3.1 siRNA sequences used in this study 
   
Target Sequence  Reference 
Luciferase 5'-UCGAAGUACUCAGCGUAAG-3' This study 
p38α 5 '-GCAUUACAACCAGACAGUUGAUAUU-3' (196) 
p38β 5'-CAACCACCAGGUGUCAAAUGAGAAA-3' (196) 
JNK1/2 5′-TGAAAGAATGTCCTACCTT-3′ (224) 
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RESULTS 
 
Set8 and Cdt1 are protected from CRL4Cdt2-dependent degradation in the 
presence of cellular stress.  
Degradation of Cdt1 and Set8 after DNA damage is dependent on the E3 
ubiquitin ligase CRL4Cdt2. We have previously shown that these proteins can be 
protected from CRL4Cdt2-mediated degradation under conditions of cellular stress 
and recapitulated those results here (Figure 3.1) (196). Addition of an 
osmoticstressor, in this case NaCl, results in stabilization of both Cdt1 and Set8 
after UV irradiation or H2O2 treatment (Figure 3.1A and B). Our lab previously 
reported that this stabilization of Cdt1 was due to phosphorylation by JNK and 
p38 stress-activated MAPKs; inhibition of both kinases restored Cdt1 (and Set8) 
degradation after UV irradiation (196). Treatment with these inhibitors also 
reversed the mobility shift representative of phosphorylated Cdt1. To explore the 
relationship between stress MAPK activity and degradation of Set8 and Cdt1, 
HCT116 cells were treated with siRNAs against p38α/β and JNK1/2 both 
separately and in combination (Figure 3.1C). After inducing osmotic stress, we 
irradiated cells with UV to induce the degradation of CRL4Cdt2 substrates. When 
cells were treated with a control siRNA (Figure 3.1C; lanes 1 and 2), both Cdt1 
and Set8 were degraded after UV irradiation. Prior osmotic stress (Figure 3.1C; 
lane 3) prevented this degradation as was previously seen with sorbitol 
pretreatment. This protection is reversed upon addition of both p38α/β and 
JNK1/2 siRNAs (Figure 3.1C; lane 4), but not with either siRNA alone (Figure 
3.1C; lanes 5 and 6). Although difficult to discern, Set8 is still present in lanes 5 
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Figure 3.1. Cellular stress prevents the DNA damage-induced degradation 
of Set8 and Cdt1. A) Both Set8 and Cdt1 are degraded after UV treatment, but 
this degradation is prevented when 250 mM NaCl is added to HCT116 cells. B) 
They are also degraded when DNA damage is induced by 100 nM H2O2. This is 
again reversed by the addition of 250 mM NaCl. C) HCT116 cells were 
transfected with control small interfering RNA (siRNA) targeting Luciferase (lanes 
1-3), siRNA molecules targeting p38α and p38β (lane 6), JNK1/2 (lane 5), or all 
four stress-activated MAPK isoforms (lanes 4 and 7) for 52 h and then treated 
with 250 mM NaCl 15 min prior to UV irradiation as indicated. Endogenous Set8, 
Cdt1, phoshpo-cJun, phospho-MAPKAPK2, p38α/β, JNK1/2 were detected by 
immunoblotting. The p38α and p38β isoforms are recognized by the same 
antibody and migrate together by SDS-PAGE. The * denotes non-specific 
background bands. 
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and 6 while completely absent in lane 4. However, treatment with siRNAs to both 
MAP kinases caused a reduction in the Set8 and Cdt1 levels in the absence of 
UV irradiation (Figure 3.1C; lane 7), but not to the same degree as treatment with 
both siRNAs with UV (Figure 3.1C; lane 4) or the absence of osmotic stress 
(Figure 3.1C; lane 2). Further experiments using different siRNA conditions 
should resolve this ambiguity as these siRNAs have been utilized previously 
without affecting Cdt1 protein levels (196). These data suggest that, in 
asynchronous cells, both p38α/β and JNK1/2 can contribute to the stabilization of 
Cdt1 and Set8. 
Set8 and Cdt1 are protected from CRL4Cdt2-mediated degradation in 
nocodazole-arrested cells.  
Given that Set8 and Cdt1 are both phosphorylated during mitosis and that 
phosphorylation can prevent ubiquitin-mediated degradation of Cdt1 and Set8, 
we investigated whether Cdt1 and Set8 were protected from CRL4Cdt2-mediated 
degradation during mitosis (Figure 3.2) (123,196). JNK, p38, and Cdk1 are all  
active during mitosis. In asynchronous cells, Cdt1 and Set8 are degraded after 
UV irradiation as expected (Figure 3.2A; compare lanes 1 and 2), but surprisingly 
both were protected from degradation in nocodazole-arrested cells (Figure 3.2A; 
compare lanes 3 and 4). This observation was initially made by J. Hall and K. 
Coleman (unpublished observations). As previously reported, phosphorylated 
Cdt1 migrates slower on the gel and this isoform is present during the 
nocodazole arrest (Figure 3.2A; compare lanes 1 and 3). Two hours after release  
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Figure 3.2. Set8 and Cdt1 are protected from UV-induced degradation in 
G2/M. A) HeLa cells were arrested in nocodazole, released into fresh media, and 
irradiated with UV at the indicated times. Cells were harvested 1 h after UV 
irradiation. B) Asynchronous and nocodazole arrested T98G cells carrying HA-
tagged wild-type Cdt1 or Cdt15A were UV irradiated and harvested after 2 h. C) 
HCT116 cells were arrested in nocodazole. Cycloheximide and MAPK inhibitors 
were added 15 min before UV irradiation. (The p38 inhibitor was SB203580, and 
the JNK inhibitor was SP600125.) Cells were harvested 90 min after UV 
irradiation. 
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from nocodazole, the majority of Cdt1 detected is in the unphosphorylated form 
(Figure 3.2A; lane 5, lower band) and is degraded after UV irradiation (Figure 
3.2A; lane 6) while the phosphorylated upper band can still be detected until 3-4 
h after release from nocodazole even after treatment with UV (Figure 3.2A; lanes 
7 – 9). Similarly, Set8 also becomes susceptible to degradation 2 h after release 
from nocodazole (Figure 3.2A; compare lanes 9 and 10). These results 
demonstrate that both Set8 and Cdt1 are again subject to UV-induced 
degradation upon exiting mitosis. Further experiments comparing the timing of 
degradation with activation of JNK, p38, and CDK are ongoing.  
 We previously mapped five phosphorylation sites on Cdt1 that were 
required for MAPK-mediated protection from UV-induced degradation (196). To 
confirm that the E3 ligase CRL4Cdt2 was still present and active in nocodazole-
arrested cells, we mutated all five of these residues to alanine (Cdt15A) rendering 
Cdt1 susceptible to degradation. We compared the degradation of this HA-
tagged Cdt15A with HA-tagged Cdt1WT (Figure 3.2B). Both constructs are 
degraded in asynchronous cells after UV irradiation (Figure 3.2B; lanes 4 and 6). 
In nocodazole-arrested cells, Cdt15A is degraded while Cdt1WT is protected from 
degradation (Figure 3.2B; compare lanes 8 and 10). This result indicates that the 
CRL4Cdt2 E3 ligase is still functional in nocodazole-arrested cells and that these 
substrates are protected during this cell cycle stage. This data indicates that 
phosphorylation at these five sites is sufficient to protect Cdt1 from CRL4Cdt2-
mediated degradation. Set8 is known to be phosphorylated at serine 29 during 
mitosis (123,201), but we have yet to determine if this phosphorylation is 
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sufficient to protect Set8 from UV-induced degradation. We hypothesize that 
there could be additional phosphorylated residues that are required for Set8 
stabilization. One potential MAPK and/or CDK phosphorylation site is T110; we 
have mutated both T110 and S29 to either alanine or aspartic acid and 
experiments with these mutants are ongoing. If our hypothesis is correct, then 
mutating these sites to alanine to prevent phosphorylation should result in UV-
induced degradation of Set8 during mitosis. 
 Given that phosphorylation of Cdt1 by stress MAPKs protects it from UV-
induced, CRL4Cdt2-mediated degradation (196), we hypothesized that 
phosphorylation by MAPKs also occurs during mitosis to protect Cdt1 from 
degradation. Set8 is phosphorylated during mitosis as well, but Cyclin B-Cdk1 is 
the only kinase currently known to phosphorylate Set8. Because JNK and p38 
are both active during mitosis, we hypothesize that Cdt1 and Set8 are both 
regulated by MAPKs during this cell cycle phase. Not surprisingly, the protection 
of both Cdt1 and Set8 observed in nocodazole-arrested cells can be reversed 
upon pharmacological inhibition of MAPK activity (Figure 3.2C). Inhibiting both 
p38 and JNK activity (Figure 3.2C; lane 5) as well as inhibiting JNK alone (Figure 
3.2C; lane 6) is sufficient to render Cdt1 and Set8 susceptible to UV-mediated 
degradation. This result is in contrast to what we observed in asynchronous cells 
treated with osmotic stress in which p38 and JNK were both required for full 
protection following UV irradiation (Figure 3.1C). These data suggest that during 
mitosis, only JNK is responsible for regulating the stability of Set8 and Cdt1. One 
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caveat to this interpretation is that the findings may be a consequence of off-
target effects caused by treatment with JNK inhibitor II (a.k.a. SP600125).  
In addition to inhibiting JNK activity, JNK inhibitor II acts upstream of Aurora-A 
kinase and polo-like kinase 1 (Plk1) to prevent Cdk1 activation (202). When CDK 
activity is inhibited in mitosis, APCCdh1 becomes active and degrades Cyclin B. 
When we treat our cells with JNK inhibitor II, Cyclin B is lost suggesting this off-
target effect occurs in our hands as well (Figure 3.2C; lanes 5, 6, 8, and 9). To 
address the issues with JNK inhibitor II, we are currently performing siRNA 
treatments in nocodazole-arrested cells to determine if there is a role for JNK in 
protecting Cdt1 and Set8 from UV-induced degradation. Additionally, we are 
conducting experiments using another more specific JNK inhibitor, JNK inhibitor 
VIII. Due to the off-target effects of JNK inhibitor II, our current data suggest that 
during mitosis, either JNK or CDKs are acting upon Cdt1 and Set8 (either directly 
or indirectly) to protect them from UV-induced degradation. 
Inhibition of Cdk1 activity, rather than JNK, reverses Cdt1 and Set8 
protection from UV-induced degradation in nocodazole-arrested cells. 
Given the off-target effects of the JNK inhibitor II, we utilized the CDK 
inhibitor roscovitine to determine if the effects on Cdt1 and Set8 degradation 
were due to Cdk1 inactivation. We can phenocopy both loss of Cyclin B and 
degradation of CRL4Cdt2 substrates by treating nocodazole-arrested cells with 
roscovitine (known to cause mitotic exit) (Figure 3.3A; compare lanes 6 and 8). 
These data indicate that inhibition of CDK activity, rather than JNK activity, is 
sufficient to render Cdt1 and Set8 sensitive to UV-mediated degradation. 
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Figure 3.3. Cdk1, not JNK, is required for protection of Set8 and Cdt1 after 
UV irradiation in nocodazole-arrested cells. A) HCT116 cells were arrested in 
nocodazole and treated with roscovitine, JNK inhibitor II, or p38 inhibitor 
(SB203580) for 15 min prior to UV irradiation. Cells were harvested 2 h after 
irradiation. The * denotes a non-specific background band in both A and B. B) 
HCT116 cells were arrested in nocodazole and treated with Cdk1 inhibitor (RO-
3306), JNK inhibitor VIII, or p38 inhibitor (SB203580) for 30 min prior to UV 
irradiation. Cells were harvested 2 h after irradiation. The arrow indicates the 
phosphorylated cJun band. C) HCT116 cells were arrested in nocodazole and 
harvested 2 h after UV irradiation.  
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Recently, Cyclin B-Cdk1 and Cyclin A-Cdk2 were shown to phosphorylate Cdt2  
at T464 during mitosis and protect it from SCFFBXO11-mediated degradation 
(203,204). When cells were treated with roscovitine or a Cdk1-specific inhibitor 
 (RO-3306), the half-life of Cdt2 was greatly reduced. In contrast to these other 
reports, Cdt2 levels were at best modestly and inconsistently reduced in our cells 
upon addition of JNK inhibitor II (Figure 3.2C; lanes 5 and 9). However, this 
reduction in Cdt2 abundance was not sufficient to impede the degradation of 
Set8 or Cdt1.  
To determine if the protection of Set8 and Cdt1 in nocodazole-arrested 
cells was due solely to Cdk1 activity, we treated nocodazole-arrested cells with 
the Cdk1 inhibitor, RO-3306, 30 min prior to UV irradiation (Figure 3.3B). 
Treatment with this drug sensitized Cdt1 and Set8 to degradation in mitosis to 
the same extent as treatment with either JNK inhibitor II or roscovitine (Figure 
3.3B; lane 5). To confirm that JNK activity was not involved, we treated with a 
more specific JNK inhibitor, JNK inhibitor VIII, and did not see any degradation of 
Cdt1 or Set8 after UV (Figure 3.3B; lane 6). However, upon examination of 
phosphorylated cJun levels, JNK inhibitor VIII failed to inhibit JNK activity in this 
experiment (Figure 3.3B; lanes 5 and 8). As the inhibitor was initially validated in 
our lab using cells treated with osmotic stress, adjustments to the timing of 
inhibitor addition may need to be made in nocodazole-arrested cells. Further 
experiments are currently underway to determine the importance Cdk1 activity, 
either directly or indirectly, for CRL4Cdt2 substrate stability during mitosis. 
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Additionally, we will repeat our experiments in nocodazole-arrested cells and 
asynchronous cells plus osmotic stress using JNK inhibitor VIII to determine if 
JNK activity is important for Cdt1 and Set8 stabilization under those 
circumstances. Pending these additional results, it remains clear that Cdk1 
activity is either directly or indirectly involved in regulating the stability of CRL4Cdt2 
substrates. 
The most obvious possibility for why Set8 and Cdt1 fail to be degraded 
after UV during mitosis is failure to interact with the CRL4Cdt2 E3 ligase. We have 
already demonstrated that Cdt2 is present in nocodazole-arrested cells (Figures 
3.3C and 3.3B); however, we wanted to confirm that Cdt2 could be recruited to 
chromatin in response to DNA damage during this cell cycle phase. Cells 
arrested in mitosis were irradiated with UV, harvested 2 h later, and the 
chromatin was isolated. Cdt2 and PCNA are clearly present in both 
asynchronous and mitotic cells (Figure 3.3C; lanes 1-4). Additionally, PCNA is 
loaded onto chromatin in both asynchronous and mitotic cells after UV irradiation 
(Figure 3.3C; lanes 5-8). Surprisingly, Cdt2 is not properly recruited to chromatin 
in nocodazole-arrested cells following UV irradiation. This result could be 
indicative of a failure to interact with its substrates during this cell cycle phase. 
We are currently conducting immunoprecipitation experiments to test this 
possibility. We hypothesize that mitotic kinases, likely Cdk1, phosphorylates 
either Cdt2 to inhibit its activity, or the CRL4Cdt2 substrates to prevent their 
interaction with Cdt1. These possibilities are not mutually exclusive and could 
both be in effect simultaneously. 
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Differential regulation of Cdt1 and Set8 during quiescence. 
Clearly phosphorylation of at least one CRL4Cdt2 substrate influences its 
degradation and it is likely that this regulatory mechanism is conserved for many 
if not all CRL4Cdt2 substrates. While our work has focused predominately on 
mitosis, Cdt1 is also phosphorylated during quiescence as evidenced by the 
slower migrating phospho-Cdt1 band (196). Interestingly, quiescence is another 
cell cycle phase that has high levels of p38, but unlike mitosis, JNK and Cdk1 
activities are low (Figure 3.3; p-cJun levels indicative of JNK activity) (205,206). 
We have utilized two cell lines in this investigation, T98G cells (glioblastoma line) 
and NHF-hTERT cells (normal human fibroblasts). T98G cells lack detectable 
levels of endogenous Cdt1 in quiescence so we created a T98G cell line stably 
expressing Cdt1. Previous work in the lab has shown that in these T98G cells, 
Cdt1 is protected from UV-induced degradation (K. Coleman; unpublished 
observation). To further investigate this phenomenon, we examined Cdt1 and 
Set8 stability after UV irradiation in NHF-hTERT cells arrested in quiescence by 
serum starvation (Figure 3.4). This cell line does express detectable levels of 
Cdt1 during quiescence. Interestingly, Cdt1 is protected from degradation as 
previously reported, but Set8 is not. Previous reports utilizing serum-starved 
HaCaT and RPE1-hTERT cells indicate that Cdt2 is degraded shortly after serum 
removal by SCFFBXO11 (203). However, this is likely not the case in our quiescent 
NHF cells (Figure 3.4) because Set8 is degraded after UV irradiation. It is 
possible that another E3 ubiquitin ligase complex is responsible for Set8 
degradation, and we are currently conducting experiments to assess if Cdt2 is 
functional during quiescence. The mechanism by which Cdt1 is protected from  
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Figure 3.4. Cdt1 is protected from UV-induced degradation during G0, but 
Set8 is not. NHF cells were serum deprived in DMEM plus 0.05% FBS for 72 h. 
JNK (SP600125) and p38 (SB203580) inhibitors were added 15 min prior to UV 
irradiation, and cells were harvested 2 h after irradiation. The arrow indicates the 
phosphorylated form of MAPKAPK2. 
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degradation is unclear. P38 is active during this phase (as indicated by p-
MAPKAPK2); however, treatment with p38 and JNK inhibitors did not result in 
Cdt1 degradation after UV (Figure 3.4). This finding raises the possibility that 
another mechanism functions specifically during this cell cycle phase to stabilize 
Cdt1 but not Set8. Experiments are currently underway to determine the 
mechanism of this highly specific stabilization. 
DISCUSSION 
 
 The data described above clearly demonstrate that phosphorylation 
mediates stability of the CRL4Cdt2 substrate Cdt1, and likely Set8, during specific 
cell cycle stages and in response to cellular stress. The work presented here 
raises some very interesting questions regarding the regulation of preRC 
components outside of G1 and S phases. Why it is beneficial for the cell to 
protect these proteins from degradation when their presence outside of G1 could 
allow rereplication to occur? Clearly rereplication does not occur in an 
unperturbed cell cycle so there must be safeguards in place to restrict the origin 
licensing capabilities of these substrates. We know this is the case for Cdt1 
because the Cdt12E3D phosphomimetic mutant cannot fully complement preRC 
formation when endogenous Cdt1 is knocked down yet, this mutant is protected 
from UV-dependent degradation (196). However, it is unclear at this time if Set8 
is able to perform its origin licensing function when phosphorylated. 
Phosphorylation of Set8 at serine 29 by Cdk1 has no effect on the ability of Set8 
to methylate H4 (123). While we have not definitively shown that phosphorylation 
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at this site is protecting Set8 from CRL4Cdt2-mediated degradation, those 
experiments are underway. 
Cdt1 and Set8 are protected from UV-induced degradation during mitosis, 
but for Set8, it is unclear why this protection at this cell cycle phase is necessary 
or favorable for the cell. In the case of Cdt1, we know it has an important role 
during mitosis to promote stable microtubule-kinetochore attachments (198). Our 
lab has shown that depletion of Cdt1 during prometaphase results in an arrest at 
this phase of mitosis. The importance of Set8 stability during mitosis is not quite 
as clear. Set8 and H4K20me1 are required for chromosome condensation during 
G2/M (111). H4K20me1 is recognized and bound by condensin II, which is 
required for chromatin condensation during mitosis (124). Additionally, L3MBTL1 
specifically recognizes H4K20me1 and is also important for chromatin 
compaction (114). However, it is unclear if de novo H4K20 methylation by Set8 is 
required or if Set8 plays another as yet uncharacterized role in mitosis. 
There are several possibilities regarding the requirement for Set8 and/or 
H4K20me1 in mitosis. First, if we consider the need for H4K20me1 for chromatin 
compaction during G2/M, there are two ways to obtain this modification. The first 
mechanism, of course, is through de novo methylation by Set8 that has 
accumulated during G2. The second is through demethylation of the higher 
methylation states, H4K20me2/3, that were deposited as cells transitioned from 
G1 to S phase. In 2012, PHF2 was identified as the demethylase for H4K20me3; 
it was previously shown to demethylate H3K9me2 (207). PHF2 activity is 
dependent on phosphorylation; protein kinase A is the only kinase to date known 
	   94	  
to phosphorylate PHF2 and it does so at four C-terminal sites (S757, 899, 954, 
and 1056) with S1056 being the major site of phosphorylation (208). While PKA 
is not cell cycle regulated, there could be other as yet unidentified mechanisms 
regulating PHF2 activity. Interestingly, PHF2 was identified in a global mass 
spectrometry study as being phosphorylated during mitosis at S37/39 and T41 
(motif: SASPTIP) (201). Cdk1 could be phosphorylating these sites during 
mitosis since the phosphopeptide most frequently detected was the S39/P site. A 
potential model for restoring H4K20me1 after S phase could involve both 
increased Set8 levels to promote de novo methylation as well as activation of the 
PHF2 demethylase to remove the H4K20me3 (and perhaps me2) that was 
deposited at the G1/S transition. It would be interesting to determine if PHF2 
protein and/or activity levels are cell cycle regulated and to determine which 
kinase is responsible for PHF2 activation during mitosis. We are currently 
conducting experiments to prevent Set8 accumulation only during G2/M and 
assess the impact on both mitosis and the subsequent G1 phase. It is also 
possible that Set8 methylates some as yet unidentified protein important for 
mitotic exit and/or origin licensing in the subsequent G1 phase.  
Despite our previous data demonstrating that p38 and JNK phosphorylate 
Cdt1 in response to osmotic stress, it is still unclear which kinases actually 
protect Cdt1 and Set8 from proteolytic degradation. The data presented here 
indicated that JNK rather than p38 is a likely candidate. However, due to the 
inhibition of Cdk1 activity with JNK inhibitor II, our previously published results 
about he role of JNK and p38 in regulating Cdt1 during G2/M must be 
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reinterpreted (196). Current efforts have been unsuccessful in reversing the Cdt1 
mobility shift with p38 and the more specific JNK inhibitor VIII, but treatment with 
the Cdk1 inhibitor RO-3306 is sufficient to reverse the Cdt1 mobility shift (Figure 
3.3B; lane 8). These data suggest that both during nocodazole-arrest and after 
osmotic stress, Cdt1 is phosphorylated in a Cdk1-dependent manner with no 
direct contribution from JNK or p38 kinases. However, it must be noted that our 
previous publication reported that upon treatment with siRNAs against JNK and 
p38, the Cdt1 mobility shift was reversed; although, this result was found in 
asynchronous cell treated with sorbitol and not mitotic cells (196). Efforts to 
perform this experiment in synchronized cells are underway.  
Interestingly, treatment with p38 and JNK inhibitor VIII either singly or in 
combination failed to restore Cdt1 (or Set8) degradation after UV irradiation (data 
not shown). In contrast, treatment with the Cdk1 inhibitor is sufficient to render 
both Set8 and Cdt1 susceptible to UV-induced degradation (Figure 3.3B). 
Therefore, while it is clear that Cdk1 is important for protecting Cdt1 and Set8 
from degradation during mitosis, we still need to determine if this is a direct 
consequence of Cdk1 phosphorylation or an indirect effect. Interestingly, Cdt2 
levels are slightly reduced upon treatment with the Cdk1 inhibitor (Figure 3.3B; 
lanes 8 and 5). However, Set8 and Cdt1 are still degraded suggesting that this 
level of Cdt2 is sufficient for their degradation, or that some other degradation 
mechanism is involved. Performing this experiment with the Cdk1 inhibitor in the 
presence of Cdt2 siRNA would resolve this matter; if another mechanism were 
involved, knock down of Cdt2 would have no effect on the degradation of Cdt1   
	   96	  
and Set8. 
Cdk1 is known to phosphorylate both Cdt1 and Set8 (123,209). Cdt1 can 
be phosphorylated by Cdk1 or Cdk2 in conjunction with Cyclin A, primarily in S 
and G2 phases; this phosphorylation promotes Cdt1 degradation by SCFSkp2. 
Phosphorylation by Cyclin B-Cdk1 is restricted to mitosis and while ablation of 
Cyclin A in Drosophila leads to rereplication, loss of Cyclin B does not (210). 
Set8 is also phosphorylated at serine 29 by Cyclin B-Cdk1, and this modification 
protects Set8 from degradation by APCCdh1. As cells enter G1 phase, Cdc14 
phosphatase removes S29 phosphorylation to allow Set8 degradation (123). We 
hypothesize that phosphorylation at this site also protects Set8 from CRL4Cdt2-
mediated degradation and experiments are underway to test this hypothesis.  
Perhaps the most interesting finding of this study is that Set8 and Cdt1 are 
regulated differently during quiescence. Cells enter quiescence after failing to 
pass the restriction point during G1. During this cell cycle stage, CDK activity is 
low and APCCdh1 is active. We have found that Cdt1, but not Set8, is protected 
from degradation after UV irradiation in quiescent cells. This result raises two 
main questions. The first question is why Set8 is present during quiescence. 
Presumably, if phosphorylation at S29 protects Set8 from APCCdh1-mediated 
degradation then, when Cdc14 dephosphorylates this site as cells exit mitosis, 
Set8 should be degraded and therefore absent during quiescence. Yet, Set8 is 
clearly present. This could be the result of Cdc14-resistant mitotic Set8 
phosphorylation by a kinase other than Cdk1. Set8 would then be protected from 
APCCdh1, but not from CRL4Cdt2 as cells entered quiescence. The second 
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question is why Set8 is protected from DNA damage-induced degradation during 
mitosis, but not during quiescence. Several hypotheses have been put forth as to 
why Set8 is degraded after DNA damage in any cell cycle stage (reviewed in 
reference 211). Since Set8 is known to be involved in chromatin compaction, it 
could restrict access to the damaged DNA if not degraded. Alternatively, it is 
known to methylate p53 and prevent transcription of p53 target genes such as 
p21 that are needed for halting the cell cycle after DNA damage. It is possible 
that Set8 is required during quiescence to prepare for G1 phase; yet in the 
presence of DNA damage it needs to be degraded so as not to inappropriately 
initiate DNA replication. It is clear that further investigations are required to gain a 
better understanding of the regulation of Set8 and Cdt1 in this cell cycle phase. 
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CHAPTER 4 
 
Conclusions and Unanswered Questions 
 
Based on our work in S. cerevisiae, it is clear that di-methylation of H3K4 
by Set1 (as part of the COMPASS complex) is required for efficient origin activity. 
Loss of this modification results in decreased origin firing and sensitivity to 
replication stress. Although the mechanism by which H3K4me2 promotes origin 
function is unclear, there are two likely possibilities that are not mutually 
exclusive. The first is that H3K4me2 is recognized and bound by a replication 
factor (such as a preRC component or PIC member). Another possibility is that 
H3K4me2 recruits another histone modifying enzyme that helps to create a 
chromatin structure favorable to origin activation. Interestingly, in human cells tri-
methylation of H3K4 by MLL1 is essential for HBO1 binding and subsequent H4 
hyperacetylation at the lamin B2 origin during G1 (99). We have hypothesized 
that in budding yeast, the HAT complex SAGA could be recruited by H3K4me2 
as a complex member, Sgf29, specifically binds this chromatin modification (168). 
Illustrating the requirement for dynamic histone modification, H3K4 methylation 
by MLL1, while favorable for origin licensing in G1, actually prevents association 
of the PIC member Cdc45 (212). MLL1 is dynamically regulated during the cell 
cycle, in part to restrict DNA replication to once per cell cycle and to prevent 
aberrant replication in the presence of DNA damage (212,213). We, too, have 
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seen that Set1 is dynamically regulated throughout the cell cycle and is 
detectable only during G1.  
What is the mechanism by which H3K4me2 promotes origin function in S. 
cerevisiae?  
 To address this question, we have begun to analyze the replication 
phenotypes upon deletion of the Sgf29 subunit of SAGA. Preliminary data 
suggest that this protein has only a small impact on DNA replication, as sgf29Δ 
cells do not quite phenocopy loss of SET1, though replication is slightly impaired 
(data not shown). We have previously attempted to determine if the recruitment 
of various replication factors to origins was disrupted in cells lacking SET1, but 
were unsuccessful due to technical difficulties; we should revisit these 
experiments since new information in mammalian cells suggests that the 
recruitment of these factors is likely affected by H3K4 methylation. We 
hypothesize that both mechanisms contribute to the positive effect H3K4me2 has 
on DNA replication. 
How is Set1 recruited to origins of replication? 
  
 Set1 and COMPASS recruitment to chromatin outside of transcription has 
been largely unexplored. During transcription, Set1 is recruited to promoters 
through direct interaction with the C-terminal domain (CTD) of RNA polymerase II 
(Pol II) that is phosphorylated at serine 5 (214). Additionally, the interaction 
between Set1 and the Paf1 complex also facilitates COMPASS recruitment to 
chromatin as Paf1 also interacts with elongating Pol II (215). However, less is 
known about how Set1 is recruited to chromatin outside of transcription. Given 
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the proximity of many replication origins to promoter regions it is likely that this 
mechanism of Set1 recruitment could also function at origins. Interestingly, a 
recent report observed reduced ORC binding at rDNA origins when Pol II was 
absent (216). Transcription was not required to promote replication, as sites of 
stalled Pol II were replication-competent. It would be interesting to determine if 
Pol II CTD S5 phosphorylation is required for H3K4me2 at origins. 
In contrast to H3K4 methylation, there is much more data indicating that 
H4K20me1 (and Set8) is a key regulator of origin licensing. We have shown here 
that Set8 protein levels are tightly regulated throughout the cell cycle and in 
response to cell stress and DNA damage. While previous reports have 
demonstrated that Set8 is degraded after DNA damage by the CRL4Cdt2 E3 
ubiquitin ligase, we have discovered that events (likely phosphorylation) during 
G2/M and upon osmotic stress can prevent this degradation. Our lab previously 
reported similar regulation of the preRC member Cdt1. Data presented here 
suggest that Cdk1 mediates these events either directly, or indirectly, as 
protection from UV-induced degradation is reversed upon addition of Cdk1 
inhibitors. While there are striking similarities in the regulation of Cdt1 and Set8, 
during cellular quiescence Set8, but not Cdt1, is susceptible to CRL4Cdt2-
mediated degradation after DNA damage. These findings raise two very 
important questions, which are addressed below. 
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Which kinase(s) phosphorylate Cdt1 and Set8 to protect them from UV-
induced degradation during mitosis? 
Many kinases are active during mitosis and we have begun to consider 
which of these might be involved in regulating Cdt1 and Set8 stability if the Cdk1 
effect we have observed is indirect. A recent paper elucidated a role for Aurora-A 
kinase in regulating Cdt1 stability in mitosis (217). During mitosis, Aurora-A 
phosphorylates the Cdt1 inhibitor, geminin, protecting it from APCCdc20-mediated 
degradation. This protection allows geminin to interact with soluble Cdt1 
protecting it from degradation by SCFSkp2. This finding is in contrast to interphase 
cells where geminin depletion causes DNA damage resulting in Cdt1 degradation 
through CRL4Cdt2 (218). As cells finish metaphase both Cyclin B1 and geminin 
get degraded, and Cdt1 is dephosphorylated and binds chromatin to promote 
MCM loading. Aurora-A, Plk1, and Cdk1 activity are highly intertwined such that 
inhibition of one causes inactivation of the others through a variety of 
mechanisms. Experiments are underway to determine which of these kinases 
might be directly regulating CRL4Cdt2 substrate stability during mitosis. 
Interestingly, several kinases were recently found to associate with Set8 
including Akt and casein kinase II (CK2) (113). Both of these kinases play 
important roles in mitotic progression. Akt was recently shown to regulate 
centrosome composition (219) while CK2 is important for spindle integrity 
through its phosphorylation of kinetochore components (220). The minimal 
consensus sequence for CK2 phosphorylation is S/T-X1-X2-D/E (where X1 is not 
a proline) and there are four such motifs present in Set8 (221). In addition, a 
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study of the phosphoproteome of Jurkat T cells identified phosphorylated 
residues at tyrosine 304 and serine 310 in the SET domain of Set8 (222). It is 
currently unknown which kinase is responsible or what effect these 
phosphorylations have on Set8 activity or regulation. 
Why are Cdt1 and Set8 regulated differently in quiescent cells and what is 
the mechanism of this regulation?  
 While Cdt1 and Set8 are regulated similarly after UV irradiation in all other 
cell cycle stages, during quiescence they are quite different. Cdt1 remains 
protected while Set8 is degraded (Figure 3.4). There is at least one possible 
reason for this differential regulation. It is possible that there is no difference with 
regard to protection from CRL4Cdt2-mediated degradation, but that another E3 
ligase specifically targets Set8, but not Cdt1, for proteolytic degradation. The 
obvious candidate would be APCCdh1. Set8 is a known target of APCCdh1 but can 
be protected from APC-mediated degradation through phosphorylation at S29 
(123). We are currently investigating whether Set8 is indeed phosphorylated at 
this residue during quiescence. Set8 could be dephosphorylated upon UV 
irradiation rendering it susceptible to APC-mediated degradation, but still 
protected from CRL4Cdt2-mediated degradation. While Cdt1 has also been 
reported to be a substrate of APCCdh1, APC-mediated proteolysis of Cdt1 is not 
highly robust, and its contribution to Cdt1 regulation may vary depending on cell 
type (223). For example, quiescent T98G cells have almost undetectable 
amounts of Cdt1 while Cdt1 in NHF cells is readily detectable (Figure 3.4).  
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The first question to be answered is whether CRL4Cdt2 is functional during 
quiescence. It was recently reported that Cdt2 is degraded during quiescence by 
SCFFbxo11 (203). We are currently examining total and chromatin-bound Cdt2 
levels before and after UV irradiation in quiescent NHF cells. We could also 
determine if Cdt1 and Set8 can interact with Cdt2 during quiescence. Assuming 
Cdt2 is present during quiescence, the next question would be does APCCdh1 
promote Set8 degradation in quiescence. We could mutate the S29 residue to 
alanine or aspartic acid and ask if the phosphomimetic mutant was resistant to 
UV-induced degradation while the S29A mutant gets degraded. Another 
possibility is that a separate mechanism functions during quiescence to protect 
Cdt1, but not Set8 from UV-induced, CRL4Cdt2-mediated degradation. There 
could be a distinct kinase that only phosphorylates Cdt1 protecting it from 
degradation. Answering these questions could lead us in the right direction to 
gain a better understanding of this differential regulation in quiescence. 
Do cells need de novo H4K20me1 during G2/M for proper origin licensing in 
the subsequent G1 phase? 
The literature to date has focused predominately on the importance of 
Set8 methylation of H4K20 during G2/M. Yet, no one has closely examined the 
consequences of Set8 depletion during this cell cycle phase for the subsequent 
G1 and origin licensing. It is still possible that Set8 methylates some as yet 
unidentified non-histone substrate that is important for mitosis, origin licensing in 
G1, or both. Is de novo H4K20me1 deposited at origins during G2/M so that 
origin licensing can commence upon mitotic exit? Or, are the higher H4K20 
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methylation states demethylated to generate the H4K20me1 that seems to be 
required for origin licensing? To begin to answer these questions we will 
synchronize cells in early S phase when Set8 is degraded and treat with Set8 
siRNA to prevent accumulation in G2/M. We will then examine H4K20me1 levels 
to determine how much demethylation of H4K20me2,3 contributes to H4K20me1 
levels in G2/M and the subsequent G1 phase. We will also look for any mitotic 
phenotypes resulting from loss of Set8. Since Set8 is known to be important for 
chromatin compaction we will use immunofluorescence to examine DNA 
compaction in metaphase and chromosome segregation in anaphase. We will 
also look for any delay in entry or exit from mitosis and G1 using flow cytometry. 
Using these methods we will begin to determine how H4K20me1 is established 
at origins and if H4K20 is the only relevant Set8 target for DNA replication.  
Concluding remarks 
 
 When this study was initiated, little was known about how individual 
histone modifications impacted DNA replication. Our efforts have characterized a 
role for H3K4me2 in promoting DNA replication and raised some important 
questions regarding the mechanism of this effect. Other histone modifications 
have been found that also promote origin activity (see Chapter 1). Additionally, 
we have shown that Set1 is cell cycle regulated in S. cerevisiae with peak 
expression during G1. This finding corroborates recent data in human cells 
demonstrating that both SCFSkp2 and APCCdc20 regulate MLL (one of six H3K4 
HMTs) protein levels to orchestrate proper gene expression and cell cycle 
transitions (213). The regulation of histone modifying enzymes is an important 
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area of research that is only now becoming appreciated. It is important to 
consider not only the regulation of histone modifications themselves, but also of 
the writers, erasers, and readers of these marks. Future work will highlight the 
dynamic nature of these enzymes and add yet another layer of complexity to the 
histone code. 
 During our studies in yeast, a novel histone modification (H4K20me1) was 
found to play a key role in origin licensing in metazoans. The breadth of 
knowledge regarding the role of the H4K20 HMT Set8 in licensing has since 
expanded rapidly. We became interested in the regulation of this 
methyltransferase and its function, not just in G1, but throughout the cell cycle. 
Our current focus is on the degradation of Set8 after DNA damage during 
different cell cycle stages and during a cellular stress response. We have found 
that Set8, and other CRL4Cdt2 targets, are protected from UV-induced 
degradation during mitosis and during an osmotic stress response. This 
protection is mediated through phosphorylation events that we are currently 
investigating. The kinases responsible for phosphorylating Set8, and other 
CRL4Cdt2 targets, are potentially different between different cell cycle stages and 
during a stress response. Overall, our efforts in both yeast and mammalian cells 
have provided further support for the importance of chromatin in regulating DNA 
replication.  
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